Podcasts about Learners

"You also want to deal with patient preferences. We do want to get their disease under control. We want to make them live a long, good quality of life. But do they want to come to the clinic once a week? Is it a far distance? Is geography a problem? Do they prefer not taking oral chemotherapies at home? We have to think about what the patient's preferences are to some degree and kind of incorporate that in our decision-making plan for treatments for relapsed and refractory myeloma," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about multiple myeloma treatment considerations. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 6, 2027. Ann McNeill has disclosed a speakers bureau relationship with Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of multiple myeloma. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 395: Pharmacology 101: Monoclonal Antibodies Episode 372: Pharmacology 101: Proteasome Inhibitors ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments New Multiple Myeloma Treatments Present New Challenges in Side Effect Management Reduce Racial Barriers and Care Inequities for Black and African American Patients With Multiple Myeloma ONS Voice FDA approval alerts ONS Voice oncology drug reference sheets: Belantamab mafodotin-blmf Daratumumab Motixafortide Selinexor Clinical Journal of Oncology Nursing articles: Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum article: Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS books: Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice (third edition) Multiple Myeloma: A Textbook for Nurses (third edition) ONS course: ONS Hematopoietic Stem Cell Transplantation™ ONS Huddle Cards: Financial Toxicity Hematopoietic Stem Cell Transplantation (HSCT) Monoclonal Antibodies ONS Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Society of Clinical Oncology (ASCO)–Ontario Health: Treatment of Multiple Myeloma Living Guideline International Myeloma Foundation: Clinical Trials Fact Sheets Clinical Trial Support Resource Library Multiple Myeloma Research Foundation resource: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Typically for our first-line therapies, we use certain classes of drugs and some of them are proteasome inhibitors like bortezomib and carfilzomib. We also have IMiDs or immunomodulatory agents like thalidomide, lenalidomide, and pomalidomide. We have monoclonal antibodies, anti-CD38 monoclonal antibodies. Of course, we can never talk about treatment for myeloma without mentioning dexamethasone. It is an integral part of our treatment regimen. Most of our frontline therapies now are not just a single agent. They're not even doublets anymore. Typically, they're triplet therapies. And now in 2026, it's leaning more toward quadruplet therapies. By that, I mean you're taking a proteasome inhibitor, an immunomodulatory drug, dexamethasone, and an anti-CD38 monoclonal antibody all together to present patients with a good chance their induction therapy will lead to a good chance of them responding to treatment." TS 4:25 "[With] myeloma labs, there should be some indication after each cycle of therapy that the treatment is working. So, you don't have to do a whole myeloma panel, but maybe getting a monoclonal protein spike, maybe getting a free light chain assay, or maybe an immunoglobulin G or immunoglobulin A level, just to see if the treatment is working. So, those labs are crucial to determine whether the therapies are working. And again, the lab improvements usually correlate with the clinical presentation of the patient." TS 11:01 "There are active clinical trials ongoing with drugs like cell mods. Cell mods are the new oral anticancer agents for myeloma that have shown great promise with efficacy and safety profiles. And then there are other combinations that are showing a lot of promise. So, drugs that are already approved by the U.S. Food and Drug Administration (FDA). And I'm talking about pairing anti-CD38 monoclonal antibodies with bispecific T-cell engagers. If you do that, there has been some evidence that these combinations are very efficacious and responses are durable. And there are ongoing clinical trials and studies being done right now to see if these can be FDA-approved to pinpoint where they are as far as in comparison to other treatments." TS 20:10 "I always tell patients to try to participate in safe, and I want to stress safe, physical activity. So, I tell patients, the more you sit on the couch or you sit in the chair for most of the day, that unfortunately will make your pain worse. So, trying to get up and about and doing some physical activity, such as getting a physical therapy evaluation and a treatment program, no matter how passive or mild or gentle it is, can really help these patients with bone pain." TS 26:10 "I think it's important to realize that myeloma has had amazing advances in science, research and treatments. I think that all of these things coming together, all the science and clinical trials and everything like that, has led to a significant increase in overall survival of our patients, which ultimately is a great thing. We want patients to live longer and they're living longer with a very good quality of life. So, I think it's important to realize that myeloma is very well studied, very well researched, and it's still ongoing with many, many clinical trials." TS 36:04

What do you do when students already know the math before you even teach it?This question came straight from a listener—and it's one we don't talk about enough. While so much attention in education focuses on supporting students below grade level, we often miss a critical (and underserved) group: the students who already “get it.”Without meaningful mathematical thinking and cognitive challenge, these students may disengage, develop surface-level strategies, or come to see math as boring and procedural. In this episode, we explore why traditional unit pacing may actually harm these learners—and what educators can do instead to deepen reasoning, sense-making, and flexibility. If you've ever wondered what comes after mastery, this conversation is for you.Listeners Will Learn:Why “early finishers” often get the least instructional support in mathHow adjusting pace can unintentionally limit access to the full landscape of grade-level mathematicsWhat it looks like to create math challenge without just assigning more problemsHow “what if?” questions and strategic mathematical constraints deepen understandingWhy abstract thinkers need to represent their thinking—and how to get their buy-inHow planning ahead (not improvising) leads to better differentiation in mathThe power of mini-consolidations to target all learners, not just the middleWhy all students—not just struggling ones—deserve access to rich, high-cognitive-demand math tasksWhether you're a teacher trying to meet a wide range of learners or a coach supporting classroom math differentiation, this episode is packed with tools and mindsets to help you stretch mathematically confident learners without sacrificing your core instruction.Not sure what matters most when designing math improvement plans? Take this assessment and get a free customized report: https://makemathmoments.com/grow/ Math coordinators and leaders – Ready to design your math improvement plan with guidance, support and using structure? Learn how to follow our 4 stage process. https://growyourmathprogram.com Looking to supplement your curriculum with problem-based lessons and units? Make Math Moments Problem Based Lessons & Units Show Notes PageLove the show? Text us your big takeaway!Are you wondering how to create K-12 math lesson plans that leave students so engaged they don't want to stop exploring your math curriculum when the bell rings? In their podcast, Kyle Pearce and Jon Orr—founders of MakeMathMoments.com—share over 19 years of experience inspiring K-12 math students, teachers, and district leaders with effective math activities, engaging resources, and innovative math leadership strategies. Through a 6-step framework, they guide K-12 classroom teachers and district math coordinators on building a strong, balanced math program that grows student and teacher impact. Each week, gain fresh ideas, feedback, and practical strategies to feel more confident and motivate students to see the beauty in math. Start making math moments today by listening to Episode #139: "Making Math Moments From Day 1 to 180.

Alexander Landa is the Co-founder and CEO of Akiva, an AI-driven immersive learning platform that helps neurodivergent individuals build skills through engaging virtual reality lessons. Driven by his experience as a father navigating special education challenges, he founded Akiva to help families, clinicians, and educators foster meaningful progress. With over 25 years of leadership in software and tech startups, Alexander brings deep expertise in building and scaling innovative products. Under his leadership, Akiva continues expanding access to inclusive, science-backed learning experiences that empower users to thrive.  In this episode… Immersive technology is changing the way people learn, connect, and grow — especially for those who experience the world differently. From virtual reality classrooms to AI-powered skill development, new tools are opening doors for more inclusive education. Could immersive learning be the key to helping neurodivergent learners thrive with greater confidence and independence? Alexander Landa, a longtime enterprise software leader and immersive learning innovator, believes it can. He explains that combining virtual reality with artificial intelligence creates a more supportive and engaging environment for individuals with autism, ADHD, dyslexia, and other neurodivergent conditions. He highlights how Akiva's platform personalizes learning through recommendation models and progress prediction, giving families and educators clearer insight into development. This approach helps learners build essential life and communication skills in a way that feels natural and empowering. He also shares why accessibility and dignity are central to the mission. In this episode of the Inspired Insider Podcast, Dr. Jeremy Weisz speaks with Alexander Landa, Co-founder and CEO of Akiva, to discuss immersive learning for neurodivergent learners. They explore how VR and AI support autism education, why Meta Quest is a powerful delivery tool, and the SPACE framework behind Akiva's approach. Alexander also shares his favorite resources and business-building lessons.

learn five words about family

Show notes at pharmacyjoe.com/episode1101 In this episode, I’ll discuss the association between number of learners trained per year and rates of burnout among inpatient pharmacists.

"Radioimmunoconjugates work through a dual mechanism that combines immunologic targeting with localized radiation delivery. The monoclonal antibody components bind to specific tumor-associated antigens such as CD20, expressed on malignant B cells. Once found, the attached radioisotope delivers beta radiation directly to the tumor, causing DNA damage and cell death," Sabrina Enoch, MSN, RN, OCN®, CNMT, NMTCB (CT), theranostics clinical specialist at Highlands Oncology in Rogers, AR, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about radioimmunoconjugates. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.25 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 30, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the history of, the mechanism of action of, and the use of radioimmunoconjugates in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 377: Creating and Implementing Radiopharmaceutical Policies and Procedures Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles ONS Voice articles: Interprofessional Collaboration Reduces Time to Neutropenia Antibiotic Administration Radiopharmaceuticals and Theranostics Offer New Options for Oncology Nurses to Transform Cancer Care Radiopharmaceuticals Pack a One-Two Punch Against Cancer Safety Is Key in Use of Radiopharmaceuticals Telehealth Has Value During Radiotherapy, Patients Say ONS Voice oncology drug reference sheets: Lutetium Lu 177 dotatate Lutetium Lu 177 vipivotide tetraxetan Radium 223 dichloride Sodium iodide-131 Strontium chloride Sr-89 ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Manual for Radiation Oncology Nursing Practice and Education (fifth edition) ONS courses: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing articles: Radiopharmaceutical Safety: Making It Easy Targeted Radionuclide Therapy: A Theranostic Approach to Cancer Therapy ONS Huddle Cards: Radiobiology Radiopharmaceuticals ONS Learning Libraries: Immuno-Oncology Radiation ONS Symptom Interventions for Prevention of Bleeding Drugs@FDA package inserts To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Radioimmunoconjugates are a specialized subset of radiopharmaceuticals designed to combine the specificity of monoclonal antibodies with the cytotoxic power of radiation. ... Early development focused on B-cell malignancies, particularly non-Hodgkin lymphoma." TS 1:51  "An important concept for nurses to understand is the crossfire effect, where radiation can affect nearby tumor cells, even though not every cell expressed has the target antigen. This helps explain why these agents can be effective even in heterogeneous tumors." TS 3:40 "At present, 90 Y-ibritumomab tiuxetan is the only radioimmunoconjugate approved by the U.S. Food and Drug Administration (FDA) in clinical use. Historically, iodine-131 tositumomab played a major role in establishing these therapy classes, but it's also useful to contrast radioimmunoconjugates with other radiopharmaceuticals, such as iodine-131 therapies, which a lot of places do at this time, used for thyroid diseases, or radium 223, used for metastatic prostate cancer. Unlike those agents, radioimmunoconjugates rely on antibody-mediated targeted rather than physiologic uptake or bone affinity." TS 4:55 "I just try to explain to [patients] that radiation exposure is like being next to a flame. The further you are away, the less heat you get, the less exposure you get. These patients can be radioactive for three days, seven days—it just depends on how fast they excrete it through their bodies with half-life exposure." TS 9:33 "While only one agent is currently approved, the principles established by radioimmunoconjugates continue to guide development for newer targeted radiopharmaceuticals. Emerging agents aim to improve targeting, reduce toxicity, and expand indications beyond hematologic malignancies. This evolution underscores the importance of nursing education in this rapidly changing field." TS 10:41 "Radioimmunoconjugates represent an important bridge between traditional oncology treatments and the future of targeted therapies. Oncology nurses play a vital role in ensuring safe delivery, patient understanding, and collaboration between multidisciplinary teams. So, it's very important to educate and also stay up to date on evidence-based practices." TS 13:12

Western Cape MEC for mobility Isaac Sileku joins John Maytham to discuss plans to make sure – vehicles transporting learners – adhere to all traffic laws to ensure learners are transported to school safely. Afternoon Drive with John Maytham is the late afternoon show on CapeTalk. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

What does it take for students with learning differences to find their voice and advocate for their own needs? In this episode, we explore self advocacy with CHC experts, Emily Hsu, PhD and Yi-Hua Lin, PsyD as a learnable skill that's critical for academic success and beyond. We'll discuss when students can start developing this ability, how it evolves from elementary through high school, and the practical strategies kids can use to speak up in the classroom—even when they feel different from their peers.We'll also tackle the parent perspective: how to build your child's confidence at home without overstepping, and how to partner with teachers to create a safe environment for self-advocacy. Whether you're a parent, educator, or advocate, you'll walk away with actionable strategies to help every learner stand up for themselves.Resources:CHC OnlineCHC's Catherine T. Harvey Center for Clinical ServicesCHC's Resource LibrarySign up for our Virtual Village email list to receive our latest episodes and recent CHC updates. Visit Voices of Compassion online for full show notes including additional resources. Find us on Facebook, Twitter, Instagram and LinkedIn and visit our YouTube channel for videos. Subscribe and leave us a review wherever you listen! We love to hear from you - email us at podcast@chconline.org.Santo Rico by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/Artist: http://www.twinmusicom.org/

Community colleges in micro-urban spaces, which are small cities with big-city dynamics, play a pivotal role in expanding access, strengthening workforce pathways, and advancing equity for Black learners. In this conversation, Dr. Terry Vaughan III highlights how these communities offer unique advantages, such as concentrated resources, reduced geographic barriers, and strong anchor institutions that can drive economic mobility. He explains to host Gianina Baker how the shift toward skills-based hiring reframes the value of credentials, emphasizing the competencies, experiences, and outcomes they represent. Vaughan also outlines his job duties at Workcred, where he focuses on building a national system of high-quality credentials, work-based learning, and transparent data to better align education with the needs of the labor market.

In Italian, there are two verbs that mean “to be”: essere and stare. When should you use each one? Find out in this simple guide! Learn about our Online Italian School and get a free mini lesson every week: https://joyoflanguages.online/italian-school Subscribe to our new Youtube channel: https://www.youtube.com/@joyoflanguages.italian?sub_confirmation=1 Get the bonus materials for this episode: https://italian.joyoflanguages.com/podcast/essere-vs-stare Today's Italian words: Sono felice = I'm happy Sono italiano = I'm Italian (m) Sono alto = I'm tall (m) Sono qui = I'm here Sto bene = I'm well Sto male = I'm not well, literally “I'm bad” Sto meglio = I'm better Stare con le persone = to spend time with people, literally “to stay with people” Stare con la famiglia = to spend time with the family, literally “to stay with the family” Stare zitto = to be quiet, to shut up Stare fermo = to stay still Stare attento = to pay attention, literally “to stay attentive” Stare calmo = to stay calm

"The United States does not have a national cancer registry. We have a bunch of state registries. Some of those registries do collaborate and share information, but the issue is the registries that do exist typically do not report cancer by occupation. So, we cannot get our arms around the potential work-relatedness of the health outcome given the current way the state registries collect information. What we're trying to set up, is a way to make what is currently an invisible risk, visible," ONS member Melissa McDiarmid, MD, MPH, DABT, professor of medicine and epidemiology and public health director of the division of occupational and environmental medicine at the University of Maryland School of Medicine in Baltimore, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 23, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the incidence of hazardous drug exposure and the tracking and reporting of healthcare worker exposures. Episode Notes  Complete this evaluation for free NCPD. University of Maryland School of Medicine Hazardous Drug Safety Center Exposure Registry information sheet ONS Podcast™ episodes: Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 308: Hazardous Drugs and Hazardous Waste: Personal, Patient, and Environmental Safety Episode 209: Updates in Chemo PPE and Safe Handling ONS Voice articles: Hazardous Drug Surface Contamination Prevails, Despite More Diligent PPE National Hazardous Drug Exposure Registry Safeguards Oncology Professionals NIOSH Releases Its 2024 List of Hazardous Drugs Safe Handling—We've Come a Long Way, Baby! Strategies to Promote Safe Medication Administration Practices Surfaces in Patient Bathrooms Often Contaminated With HDs, Despite Use of Plastic-Backed Pads ONS books: Safe Handling of Hazardous Drugs (fourth edition) Safe Handling of Hazardous Drugs Quick Guide™ ONS course: Safe Handling Basics Clinical Journal of Oncology Nursing articles: Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses' Exposure in Ambulatory Settings Personal Protective Equipment Use and Surface Contamination With Antineoplastic Drugs: The Impact of the COVID-19 Pandemic Sequential Wipe Testing for Hazardous Drugs: A Quality Improvement Project The Use of Plastic-Backed Pads to Reduce Hazardous Drug Contamination Oncology Nursing Forum articles: Ensuring Healthcare Worker Safety When Handling Hazardous Drugs Factors Influencing Nurses' Use of Hazardous Drug Safe Handling Precautions Other ONS resources: ONS Safe Handling of Hazardous Drugs Quick Guide Introduction to Safe Handling Huddle Card Safe Handling of Hazardous Drugs Learning Library Hematology/Oncology Pharmacy Association (HOPA) course: Safe Handling of Hazardous Drugs National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings, 2024 To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We thought that in order to answer some of the unclear questions about health risk, we would set up an exposure registry, in this case, for oncology personnel who handle the drugs. This would then create a cohort that we could ask questions to. For example, we could try to characterize whether there is a cancer excess in this group. Or characterize the reproductive abnormalities in excess that people are experiencing." TS 6:21 "It's sort of counterintuitive that the healthcare industry, whose mission itself is care of the sick, is a high-hazard industry. We typically think about the risk as being from infectious diseases, and certainly we've all lived in our practice lifetime through some examples of that. Even before COVID-19, some of us were doing preparation for Ebola and that sort of thing. So, we're kind of used to that. But the hazards that you kind of grew up with, we've routinized or normalized handling group one, human carcinogens, which a number of these drugs are—it's just something we do every day. Well, it is, but we have to do it with respect and with care every day. And I think sometimes in that routineness of it, we have sort of lost sight of the vigilance that we need to maintain." TS 11:19 "It's very easy in the life cycle of a drug in an organization to do something that doesn't just impact you, but unknowingly, you've contaminated a surface for somebody who comes behind you. Who maybe doesn't have plastic protective equipment on because something that got contaminated shouldn't have been contaminated in the first place. If we could all be thinking of it as more of a team sport, especially in terms of safe handling, that our disposition and drug handling affects not just us and our health, but those of our colleagues." TS 24:47 "For the job history pieces, we ask what year you started, what year you stopped, and we ask about estimations of handling. So we'll be able to come up with either a duration or some kind of metric for the intensity and duration of your handling history, which will then permit us to sort the population who completed the survey into sort of low, medium, high. And we'll see whether the health outcomes that are being reported are influenced by that drug handling history." TS 27:45 "The idea that we aren't exposed to the same therapeutic dose we give to our patients is absolutely true. However, the dosing schedule to them versus us is very different, and we are exposed frequently, if not daily, to very small concentrations. They don't reach a cytotoxic dose necessarily, but we do know from a lot of studies that either ourselves or our colleagues are taking up drug from contaminated work environments. And you've probably seen there is an awful lot of intermediate evidence looking at genotoxic insult in pharmacists and nurses who handle the drugs. So clearly we're showing uptake and we're showing that there are biologically plausible, concerning measures that are taking place in us. So, I think that we need to come back and circle around the idea that we need to have deep respect for the toxicity of these agents." TS 35:03

learn five words related to tourism

learn more about word order in long sentences with this video conversation

discover effective strategies and tips for learning Vietnamese

Clement Manyathela and the listeners discuss the board of peace that seeks to form a new international organization, they further discuss the consequences that the driver of the vehicle that killed 12 pupils in Vanderbijlpark should face. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Recorded live at the National Association for Gifted and Talented (NAGC) Conference in Pittsburgh, this final episode of the Winter 2026 Listen & Learn series brings together Dr. Matthew Worwood and Dr. Cyndi Burnett with emerging scholar Jimmy Wilson and researcher Dr. Julie Delgado. Together, they explore how creativity can become a powerful pathway for twice-exceptional (2e) learners—particularly students with autism spectrum disorder—by centering passion, projects, peers, and play. This conversation bridges research and practice, drawing from Project 2EASD and the Lifelong Kindergarten Lab's Four P's Framework (Passion, Play, Projects, Peers) to reimagine how schools and universities can support neurodiverse learners.   Episode Highlights What twice-exceptional (2e) really means—and why creativity matters How Project 2EASD reshapes professional learning for teachers The Four P's of creative learning: Passion, Play, Projects, and Peers Why interest-based peers matter more than same-age peers The role of extracurriculars, clubs, and mentorship in student growth Moving beyond deficit-based views of neurodiversity How passion fuels perseverance—and when it's okay to pivot “Hard fun” as a catalyst for leadership, confidence, and real-world skills From launching clubs to hosting dorm-room tea parties, the stories shared highlight how creative environments empower students to thrive—academically, socially, and personally. About the Guests Jimmy Wilson Jimmy Wilson is an emerging scholar and resident expert in gifted education, specializing in twice-exceptional (2e) learners. His research focuses on supporting neurodiverse students—particularly those on the autism spectrum—through creative learning experiences, mentorship, and interest-based peer connections. Jimmy brings both scholarly insight and practical strategies for implementing programs that help 2e learners thrive academically, socially, and personally. Julie Delgado, Ph.D. Julie Delgado is a tenure-track researcher in gifted education, having recently completed her dissertation on Project 2EASD (Twice-Exceptional Autism Spectrum Disorder). Her work centers on professional development for teachers, integrating creativity into learning, and helping educators cultivate meaningful experiences for neurodiverse students. Julie's research emphasizes passion-driven projects, mentorship, and leveraging extracurricular activities to promote leadership, collaboration, and real-world skill development.   Be sure to subscribe on your favorite platform and sign up for our Extra Fuel newsletter for more resources and inspiration. Visit FuelingCreativityPodcast.com for more information or email us at questions@fuelingcreativitypodcast.com.

The demographic of students in California is changing and education must change with it. Dr. Salvatrice Cummo is joined by Eloy Ortiz Oakley, President and CEO of the College Futures Foundation, to unpack the challenges facing a massive and underrepresented sector of today's learners—students primarily over the age of 25 who are working at the same time as attending school. They cover the impact of outdated educational models, the rapid pace of technological change, and the urgent need for flexibility and employer partnerships. Tune in for a forward-thinking discussion on disrupting tradition and embracing true urgency in reimagining the future of work and learning. You'll learn: How institutions can remain relevant as learners seek education that directly fuels economic mobility. What the demographics of higher education students look like today and why constant re-skilling and up-leveling is a requirement for the current workforce.  How community colleges can better personalize learning experiences to fit the needs of diverse students, rather than relying on "one size fits all" approaches. How to address the unique challenges facing working learners who juggle multiple responsibilities along with their education. About the Guest: Eloy Ortiz Oakley is an American educator, leader, and advisor. He is the President and CEO of the College Futures Foundation, where he leads California's premiere philanthropic and post-secondary success organization focused on improving economic mobility for underserved learners through the lever post-secondary credential attainment. Previously, he served as Chancellor of the California Community Colleges for six years, leading the nation's largest and most diverse system of higher education. He is considered a leading voice on improving equity in higher education and positioning institutions for the global shifts in the workforce and the future of learning. Engage with us: LinkedIn, Instagram & Facebook: @PasadenaCityCollegeEWD Join our newsletter for more on this topic: ewdpulse.com Visit: PCC EWD website   More from Eloy Ortiz Oakley & College Futures Foundation: LinkedIn: @Eloy Oakley & @College Futures Instagram & Twitter: @collegefutures Website: https://collegefutures.org/   Partner with us! Contact our host, Salvatrice Cummo directly: scummo@pasadena.edu Want to be a guest on the show? Click HERE to inquire about booking  Find the transcript of this episode here Please rate us and leave us your thoughts and comments on Apple Podcasts; we'd love to hear from you!

A winter count is history in pictures. But a 200 year-old notebook written in the Lakota language shows just how important the written word can also be. Around the globe communities are recognizing the invaluable role language plays in holding and sharing our people's stories. Many languages are so at risk that the UN declared the International Decade of Indigenous Languages to raise awareness and mobilize communities. Halfway through that decade, Rosanna hears from language learners and speakers who are reclaiming and revitalizing their languages.

"[Multiple myeloma] is very treatable, very manageable, but right now it is still considered an incurable disease. So, patients are on this journey with myeloma for the long term. It's very important for us to realize that during their journey, we will see them repeatedly. They are going to be part of our work family. They will be with us for a while. I think it's our job to be their advocate. To be really focused on not just the disease, but periodically assessing that financial burden and psychosocial aspect," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about multiple myeloma. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 16, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the pathophysiology and diagnosis of multiple myeloma. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 332: Best Nursing Practices for Pain Management in Patients With Cancer Episode 256: Cancer Symptom Management Basics: Hematologic Complications Episode 192: Oncologic Emergencies 101: Hypercalcemia of Malignancy ONS Voice articles: AI Multiple Myeloma Model Predicts Individual Risk, Outcomes, and Genomic Implications Cancer Mortality Declines Among Black Patients but Remains Disproportionately High Financial Navigation During Hematologic Cancer Saves Patients and Caregivers $2,500 Multiple Myeloma: Detecting Genetic Changes Through Bone Marrow Biopsy and the Influence on Care Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Nurse-Led Bone Marrow Biopsy Clinics Truncate Time for Testing, Treatment Diagnose and Treat Hypercalcemia of Malignancy ONS books: BMTCN® Certification Review Manual (second edition) Multiple Myeloma: A Textbook for Nurses (third edition) Clinical Journal of Oncology Nursing articles: African American Patients With Multiple Myeloma: Optimizing Care to Decrease Racial Disparities Music Intervention: Nonpharmacologic Method to Reduce Pain and Anxiety in Adult Patients Undergoing Bone Marrow Procedures Other ONS resources: Financial Toxicity Huddle Card Hypercalcemia of Malignancy Huddle Card Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Cancer Society article: What Is Multiple Myeloma? Blood Cancer United educational resources page International Myeloma Foundation homepage Myeloma University homepage Multiple Myeloma Research Foundation (MMRF) article: Understanding Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Epidemiologically, myeloma is a cancer of older adults. The median age is about 69. It is more common in men than women. It's a ratio of about three men to two women that are diagnosed. It is much more common in people of African American descent with increasing global incidence linked to aging populations. Although, the highest rates are in high-income countries. So, if we look at some of the risk factors, and several have been identified, including MGUS. MGUS is a benign precursor of myeloma, and it stands for monoclonal gammopathy of undetermined significance. Older age is also a risk factor, although we do see patients that are younger who are diagnosed with myeloma." TS 1:54 "Bone pain, specifically in the back, and fatigue, are very common symptoms that relate to things that are going on behind the scenes with myeloma. But also, patients can be bothered by frequent and long-lasting infections. So, they find that they get sick more frequently than their family and friends, and they take a longer time to recover. That could also be a presenting sign. I think there can be some presenting signs and symptoms related to electrolyte abnormalities, especially in later stages. They might be nauseated, vomiting, or constipated. Also, signs and symptoms related to cytopenias. You have to remember that this is a bone marrow cancer. So, we do have some problem with development of normal blood cells. So, we can see not only infections, but bleeding issues related to thrombocytopenia and factors related to anemia from low red blood cell counts." TS 7:15 "About 20%–25% of our patients who are diagnosed are asymptomatic. They have no symptoms. They're living their lives, they're going to work or they're traveling, playing golf on the weekends, taking care of their children or grandchildren. They are just living their lives. And at times, they go to the primary care physician and then they're referred to a hematologist-oncologist, and they're pretty surprised when they're sent to a cancer center. The way they are diagnosed in this matter is that their routine lab work, the complete blood cell count may be normal, there may be some slight differences in their hemoglobin. But what we see in the chemistry, the complete metabolic panel, is an elevation in their total protein and or an elevation of the total globulins." TS 9:22 "The bone marrow biopsy serves many purposes. You want to determine the percentage of bone marrow plasma cells. So, you want to get the degree of plasmacytosis. And then you want to do really specific tests on those plasma cells. So, you want to isolate the malignant plasma cells and determine, via analysis. So, we do the karyotype, chromosomal studies, fluorescence in situ hybridization (FISH) studies, immunohistochemistry studies, and molecular studies. All of these studies are looking for specific genetic changes in the myeloma cells—looking for translocations or deletions. And it's very important to get that information because we can put patients in a category of having standard-risk disease versus high-risk disease. And that can give us a better picture of what this patient's journey with myeloma may look like." TS 13:41 "When I used to work in lymphoma, I spoke with the physicians who were lymphoma specialists, and they said that they foresee a future in having these assays that detect circulating tumor cells actually take the place of imaging studies like restaging positron-emission tomography (PET), computed tomography (CT) scans. So, it's really amazing, these tests that are on the market now and maybe not as widespread as we'd like, but there's a lot of nice assays out there that will become more popular and used more commonplace in the future that I think are going to help identify myeloma more precisely. ... If you think about myeloma, even with measurable residual disease (MRD), MRD for leukemia, for lymphoma, you take a blood sample, you test it for MRD. For myeloma, you need a bone marrow biopsy. You need a bone marrow sample. You can't do MRD on a blood sample for myeloma. Not yet. But if we perfect these assays and we can eventually detect this, then you're looking at a whole new ballgame. You can even perfect your MRD testing as well. So, it's a very exciting time for some of these heme malignancies." TS 28:09

In this episode, Diana's special guest Jake Doberenz, founder of Theophany Media and host of the Creatively Christian podcast, shares his expertise on effective Bible study. The discussion covers essential principles of biblical interpretation, the importance of studying scripture in community, and approaches to understanding difficult passages. Listeners are also guided on selecting appropriate Bible translations and utilizing various online resources, ensuring a comprehensive and balanced approach to scripture study. The episode concludes with a prayer for listeners' spiritual journey and their engagement with the scriptures. Bio: Jake Doberenz isn't one thing. He identifies as a polymath, a Renaissance man, or a multipotentialite–one interest or specialty can't contain him. But enough of the third-person. I am a writer, speaker, minister, and creative thinker living in Oklahoma City, OK with my wife Samantha. My most significant role is the founder and president of Theophany Media, a Christian education company dedicated to helping Christians engage with culture through new media. I have earned my Master of Theological Studies at Oklahoma Christian University, the same place I earned my Bachelor's degree in Bible with a minor in Communication Studies. I also worked at my alma mater as a Resident Director and Bible TA. I write fiction and nonfiction in a variety of mediums, including poetry, short stories, books, stage plays, academic essays, and devotionals. I also venture out into other mediums, like podcasts and video. My favorite topics of choice to discuss and write about (though always changing) include: creating Christian art, helping people understand the Bible better, Christian identity, theology of social media, use of humor in faith messages, superheroes and theology, and a Christian response to culture. If you want to see his progress, achievements, and appearances sign up for the newsletter so you'll never miss an update! website: Home – Jake Doberenz 00:00 Introduction and Sponsor Message 00:47 Welcome to the Podcast 01:44 Introducing the Guest: Jake Doberenz 02:43 Jake's Background and Interests 05:56 Jake's Teaching Journey 10:46 Bible Study for Abuse Survivors 13:25 Choosing the Right Bible Translation 18:42 Understanding the Bible Without Knowing Greek or Hebrew 21:34 Basic Rules of Bible Interpretation 25:43 Embracing Uncomfortable Bible Stories 26:47 Using Jesus as a Lens for Interpretation 30:54 The Importance of Community in Bible Study 34:14 Red Flags in Spiritual Leadership 37:02 Recommended Bible Study Resources 41:33 Exploring Different Perspectives 44:58 Connecting with the Speaker 46:29 Closing Prayer and Final Thoughts   Website: https://dswministries.org Subscribe to the podcast: https://dswministries.org/subscribe-to-podcast/ Social media links: Join our Private Wounds of the Faithful FB Group: https://www.facebook.com/groups/1603903730020136 Twitter: https://twitter.com/DswMinistries YouTube: https://www.youtube.com/channel/UCxgIpWVQCmjqog0PMK4khDw/playlists Instagram: https://www.instagram.com/dswministries/ Facebook: https://www.facebook.com/DSW-Ministries-230135337033879 Keep in touch with me! Email subscribe to get my handpicked list of the best resources for abuse survivors! https://thoughtful-composer-4268.ck.page #abuse #trauma Affiliate links: Our Sponsor: 753 Academy: https://www.753academy.com/ Can't travel to The Holy Land right now? The next best thing is Walking The Bible Lands! Get a free video sample of the Bible lands here! https://www.walkingthebiblelands.com/a/18410/hN8u6LQP An easy way to help my ministry: https://dswministries.org/product/buy-me-a-cup-of-tea/ A donation link: https://dswministries.org/donate/ Jake Doberenz [00:00:00] Special thanks to 7 5 3 Academy for sponsoring this episode. No matter where you are in your fitness and health journey, they've got you covered. They specialize in helping you exceed your health and fitness goals, whether that is losing body fat, gaining muscle, or nutritional coaching to match your fitness levels. They do it all with a written guarantee for results so you don't waste time and money on a program that doesn't exceed your goals. There are martial arts programs. Specialize in anti-bullying programs for kids to combat proven Filipino martial arts. They take a holistic, fun, and innovative approach that simply works. Sign up for your free class now. It's 7 5 3 academy.com. Find the link in the show notes. Welcome to the Wounds of the Faithful Podcast, brought to you by DSW Ministries. Your host is singer songwriter, speaker and domestic violence advocate, [00:01:00] Diana . She is passionate about helping survivors in the church heal from domestic violence and abuse and trauma. This podcast is not a substitute for professional counseling or qualified medical help. Now here is Diana. Hey there, everybody. Come on in, set for a spell. How are you guys doing? I appreciate your support in listening to the podcast, and I hope that you are enjoying some really encouraging words and practical things for you to do your own Bible study and read the word of God for yourself. We have a new guest on the show now I'm very familiar with his podcast, creatively Christian. I've been on his podcast. His show has a few different interviewers. And so [00:02:00] Andrea Sandifer, who you guys know that was on the show, she interviewed me on her show. And our guest today, Jake Doberenz, the man behind that podcast, he is a funny guy. He likes to bring humor from the Bible. And I've been reading his blog and following his newsletters. And his Facebook group. So I thought he would be a great addition to the podcast , and I think you're gonna love him. I'm gonna tell you a little bit about him. He has a lot of interest here, so here we go. Jake, Doberenz isn't one thing. He identifies as a polymath, a renaissance man or a multipotentialite. One interest or specialty, can't contain him. So he [00:03:00] says of himself, but enough of the third person. I'm a writer, speaker, minister, and creative thinker, living in Oklahoma City, Oklahoma. My most significant role is the founder and president of Theophany Media. A Christian education company dedicated to helping Christians engage with culture through new media. I have earned my Master of Theological studies at Oklahoma Christian University, the same place I earned my bachelor's degree in Bible with a minor in communication studies. I also worked at my alma matter as a resident director and bible ta. I write fiction and nonfiction in a variety of mediums, including poetry, short stories, books, stage plays, academic essays, and [00:04:00] devotionals. I also venture out into other mediums like podcasts and video, my favorite topics of choice to discuss and write about. Although always changing, include creating Christian art, helping people understand the Bible better. Christian identity, theology of social media, use of humor in faith messages, super heroes and theology, any Christian response to culture. So this is gonna be awesome. So I hope that you enjoy my conversation with Jake Doberenz. Please welcome to the show, Jake Doberenz. Thanks for coming on today. Sure thing, anytime. I'm glad to be here. I really enjoyed being on your [00:05:00] podcast, A creatively Christian, and Andrea interviewed me and then she was on my podcast and I follow your Facebook group and get your. Very humorous email newsletter. And so I thought you were the perfect fit to come on to the podcast. And you're a bible geek like me, and you have a different perspective on life. In the Bible, you find humor in the Bible, which a lot of people don't find the Bible very funny. So welcome to the show. Yeah, I'm glad to be here providing some humor and quite possibly even some wisdom and intelligent comments. We'll see if we get to that part. So you haven't been on the podcast before, so. Tell the folks a little bit about yourself and your family. Okay? Yeah. Always a fun question because where do you [00:06:00] start? Where do you end? But yeah. I am in Oklahoma City right now. I'm an Oregon native and got stuck in Oklahoma. Stuck sounds too negative, but I got planted here. That sounds better. I got my bachelor's degree in biblical studies with a minor in communication studies. I have a Master's of Theological studies and for a while I was kind of going down the Bible professor route. That was gonna be my thing. And it's not like completely off the table right now, but it is not my chief kind of path anymore because there are not a lot of jobs in that area and there's a lot of different things there that make it quite challenging. A lot of schooling, a lot of debt for maybe not so much reward, but we'll see what the future brings. I am still flexing my desires to write and teach. That has always been what I wanted to do, even when the subject changed, even when it [00:07:00] was cat psychology or whatever, I always wanted to write and teach and so I'm still doing that in in different ways. I'm certainly still using my degrees, even though I'll be going into teaching middle school geography this year. Ooh, kind of a new adventure. Add some more skills and weird things on my resume. That's kind of how I do it. So geography. Cool. I think that's me. Yeah. Yeah. That's very brave. Middle school, that particular age, did you pick the age group you were teaching or did they just kind of throw you in there? I applied to high school and middle school. I wasn't going to do anybody under middle school and the high school jobs never called me back. And the, I got some different offerings on the middle school side of thing, so I said, okay, that's what you want me to do. God, I will walk into this wilderness. And then they gave me some kind of choices between, and I chose sixth grade specifically, so I'll be with, with sixth graders. [00:08:00] They, uh, we still have some childlike heart and wonder. They're not so jaded like they get when they're a little older, but they're just mature enough where you can start to get a little more serious. So good age. Hmm. I liked sixth grade. It was a good year. We'll be praying for you either way, because that's a lot of work and mm-hmm. But geography's cool. I like Bible geography. Ever since I went to Israel in 2019. How different reading the Bible is when you've been to those places. Have you been to Israel? I haven't. No, I haven't. Yeah. If you're into geography, you would really love going to Israel for obvious reasons, of course, but geography, it just makes the Bible come alive when you've been to the place where Jesus put legion into the herd of pigs and over the cliff. Sure. And I've been to that cliff, and so you can see it now in your head. It's awesome. Or you've been on the Sea of [00:09:00] Galilee and you can actually imagine Jesus walking on the water and because been in the boat. So, yeah, I'm just getting into being interested in geography right now. There you go. Yeah. Cool. What would you say is your particular specialty as far as Bible goes? Yeah. I did my master's thesis on Paul's view of spiritual formation, specifically from one Corinthians chapter three, verse three. Four, just around there. So that's a very specific kind of thing. Most of my training has actually been more on the New Testament side. Specifically Paul, I've done a lot of more academic work with the use of children as a metaphor in the Bible. I've done work with that in both Paul and the Gospels. Sexuality in the New Testament has been something I've kind of explored. [00:10:00] Nowadays though, I have more of theological interests and I'm asking some different kinds of questions. You don't divorce theology from the Bible, but they're just different kinds of questions and different kinds of, and ways and sources for that. But in terms of Bible, yeah, a lot of studying Paul and a lot of thinking about sort of how he makes arguments and specifically like in that thesis, it was all about how he used this metaphor about. Being an infant in Christ, what does all that mean? And how does that reflect how we grow as people? And so I've gone down those kind of rabbit trails a lot my my day. That's really interesting. A Paul's usually a favorite Bible character. Most people, though you can, you never go wrong with the Apostle Paul now. So today we're talking about Bible study for abuse survivors. And reason why we're doing this is because when we've gone through abuse, usually there's some spiritual [00:11:00] abuse involved and we want to distance ourself from God because we've experienced that spiritual abuse and that affects our relationship with God. And a lot of people once they leave or get out of the abuse. Then they're like, okay, I don't wanna read the Bible, I don't wanna pray, and I don't wanna go to church anymore. I don't trust anybody. But I'm trying to encourage on this podcast to come and if you have questions, let's talk about the questions. So, so I've kind of answered my own question, why should we study the Bible for ourselves? But what would you say to that or add to that? Yeah, I think what I would add to that is that, um, one thing that our teachers or pastors or scholars don't have is that they're not you. You are yourself and you come with your experiences and you come [00:12:00] with your own personality and identity, and you are gonna often pick up things that other people might miss, or you're gonna just sort of focus on things more realize as a thread of a theme or something like that. We, we shouldn't come to the Bible biased necessarily, or with too many preconceived notions. 'cause then the text starts to say what we want it to say. That's not what I'm saying. But we do bring ourselves to the text and we have to admit that like, I'm not reading this in a vacuum. I'm reading this because of who I am and what I've experienced and all these things like that. And I think that's really powerful. And I think the Bible is, it's strong enough to take it. Like it's not about pulling whatever meaning you want from it, like I said, but it is about seeing things that are hidden in this multi-layered onion like text here that has so much stuff in it that we can't expect. Even a really smart [00:13:00] guy to just know everything. So yeah, we gotta study the Bible for ourselves. We gotta do our own digging and our own reading. See what we can find. Yeah, I like that answer. Bringing yourself to the table that's. Different than what somebody else would bring to the table. So let's start with something everybody asks about. When it comes to Bible study, you go to the bookstore and you're trying to pick out a Bible, and there's a gazillion different Bible versions out there, and too many versions, in my opinion. Which one do I pick? Does it matter? At the end of the day, it probably doesn't matter. There are those that are better than others, and I'm the term better here. You can use that in different ways. I'm using the term better as in. More accurate to the text, although, hey, we are translating language here. [00:14:00] Translation is an art, not a science, which makes us a little uncomfortable. We can still get that meaning across. You're a, you're an artist and you're a creative. You can still communicate accurately and faithfully even through a song or something like that. And so in the same way, translation is a little bit of an art form and there are people that have to choose certain words, and I think this means that. So yeah, there are some that are more quote unquote scholarly and others that are more paraphrased, like the message, or it's something like the amplified Bible that is just trying to sort of squeeze some more possible meaning out there by becoming like glorified the Sorut. So you got some different options. Most readings are probably not gonna hurt you, at least. As long as you understand like kind of what's going on here. I know in the past the King James has had the word unicorns in it and that that threw some people off and then later we're like, actually we should have translated that. Like Gazelle was not supposed to be translated unicorn. So [00:15:00] okay, we can get some things here that might throw some people off, but as long as we kind of give some grace to the translators, something like the King James is older and we have some different data. We have some older manuscripts that we're pulling from now. So yeah, it's gonna be a little bit more closer to what the originals were saying kind of thing. So yeah, there are those considerations, but I don't think you're gonna make or break your faith if you read the ESV over the NRSV or something like that. Yeah, well I came from a camp that, uh, they were very definitive in what Bible you should read and which ones you should not read and Sure. And they were very dogmatic in that I've changed my stance since then. Because I've actually dug into that sort of thing that okay, you, so you're saying that most of the mainline translations out there, we will still get the main [00:16:00] point of what Bio was trying to say. Right. Yeah, I don't know any that are too left field and crazy or something like that. There are versions, like, I could be wrong about this, but I think the Jehovah's Witness has versions of the Bible that seem to play a little fast and loose with some things and have cut out some different stuff. So obviously I wouldn't necessarily recommend that for Christians. The only other thing I would say is make sure a bunch of different people were involved. Most translations are. Large groups of people. And then you have things like I mentioned the message that Eugene Peterson did, it was just him, but he wasn't necessarily trying to make a definitive thing. That's more of a paraphrase translation, which is like a devotional rather than something to study. So there are just different uses for all these different things. There are, I could go into the weeds. My dad used to own a Christian bookstore. Oh. And so you have your thought for thought translations and then you have your word for word. And [00:17:00] some people think word for word is better because it's more accurate. But the thing, the problem is the Bible might literally say X, but when we translate that word to today, it makes no sense because language is weird like that. And then so the thought for thought is going to be more of an interpretation, but they're trying to say, okay, but what this is trying to say is this and, and here's a thought that you can digest and that makes sense to you. So it's just kind of what you want, but thanks to the internet. In fact, on another screen here, I have pulled up Bible gateway.com. That's what I use a lot. You can look through all sorts of different translations and compare and contrast. If I really wanted to study with more than one, it's legal in most states, so go for it. It's funny you mentioned the message because that was my first Bible when I got saved. My okay friend that I met in high school, I told her I had gotten saved and I didn't have a Bible, and she gave me the message, which [00:18:00] was her Bible, and I loved it. Oh yeah. I highlighted that thing and Oh yeah. And I just tore it up with underlining and I couldn't wait to read it. And then of course you get to Bible college and they tear it out of your hands, so yeah. But yeah, I like the ESV today. I have. A really nice archeology study Bible I bought and I've, I've read the King James most of my Christian life. And switching to another translation was really eye-opening. All this different stuff that I hadn't seen before just popped out, like I didn't know the Bible said that. Wow. It's pretty neat. So along the same lines, do we have to be a Greek and Hebrew scholar to understand the Bible? I hope not because I struggled through Greek and barely made that alive, and so languages are not my strong [00:19:00] suit. Uh, but I think the answer is of course, no. You don't have to be. It depends on what kind of study you're doing, and I probably should have mentioned that earlier, but there's a way to look at the Bible in an academic, scholarly way, and there are some Christians that. Think that's wrong or bad? I don't think it's bad. It's just one way to look at it. When I am in scholarship, when I'm writing this college paper, I am, I have to kind of slice and dice it and I'm doing a work that an atheist could do. It's that kind of work. But then there's another way to look at the Bible that is much more pastorally or for spiritual formation, the kind of thing that treats the text as sacred that an atheist can't do. So if you're doing the academic work, it really helps to know the words because you're trying to get as precise as possible and getting into there. But luckily for us, other people have done the work for us and we have these English translations, so woo. You don't need to know Hebrew and Coin a Greek and [00:20:00] a little bit of Aramic and like Daniel or whatever. Like we don't have to know that because somebody else has done the work for us. And I mentioned already like. There's a lot of people involved in a Bible translation, not just one guy. It's, a lot of people have done this work and they've argued and yelled at each other and come to some conclusions to say, this is the best we can do right now. This is what we got. So, yeah, we don't have to, we don't have to be language PS so, woo. Lucky. Yes. Yeah. I mean, I'm a language geek. I love languages. Personally, I speak two languages besides English, but I haven't taken any Greek or, or Hebrew, maybe someday, but they didn't cover that in my Bible college. But it's good that we already have the tools online that, hey, this is a translation for that word in. There's really no, no real argument about it is there along mainline denominations. Yeah. Most people probably aren't gonna tell you. You have to know all those languages unless somebody there. There are groups of people that would say [00:21:00] the only inspired text of the Bible is the actual original Greek and Hebrew. And so our English translations are not inspired. But that's a minority view. That's not super common. Yeah. Yeah. The most people can understand. The inspiration still comes through, even when it's translating different languages. The word of gods for the whole world, not just those that can speak actually dead languages that nobody speaks today like Latin. Yeah. So now we're gonna get into the nitty gritty here. Okay. When we are sitting down with our Bible and we're deciding to. Study a passage of scripture or maybe a book. What are some basic rules of interpretation? Now we use the fancy big word hermeneutics, but like the basic ones that you really shouldn't ignore in order to. Do a proper Bible study. This is one that gets definitely drilled [00:22:00] into in Bible school and in other contexts, but it's that actual, it's a word context like context is key. Context is king, and one of the best things we can do is zoom out. So if we're looking at a particular scripture. Like one verse, we zoom out to the chapter. Those headings or whatever aren't like God inspired or whatever, but they're helpful to kind of see what the flow of things are. Then we can zoom out to the book level and sometimes zoom out to the biblical level and things like that. But that is always key. Sometimes we get into trouble thinking that the Bible is just like, the whole thing is like Proverbs, where everything's just disconnected and you got these good one-liners and they're fun and they're good zingers, but most of it is some kind of story or, and Paul, I mentioned that being some of my background, Paul's letters are arguments they build on top of each other, and so you can see if we're trying to look at something wild like. One [00:23:00] Corinthians 14 or something, we can understand it because by just kind of going a little backwards and Oh, okay. So that's always really important. And a lot of times authors in the Bible will also tell us kind of their themes and tell us what they really want us to get across. The gospel of John, for instance, is written so that we may believe Luke talks about writing in a, an orderly account of things. So we have some of these statements that if we zoom out a little bit, oh, okay, we can make sense of this in light of that. And so different things like that. But we could go all day into the hermeneutics and then the other fancy word, X of Jesus and that kind of stuff. But at the end of the day, a tool anybody can use is something I learned in elementary school when there was a hard word. It was called rat read around the text. Read around the text. Ooh, that's the acronym there. And that just helps us understand, wait, what is going on? What does Paul mean when he says this? Why is [00:24:00] this guy saying this in judges? Let's take a look. What else is going on here? So it's just a great tool that anybody can use be if they can just zoom out a little bit and read the rest of the Bible and the rest of the passage. Everybody gives a different answer to that question. Now, obviously when we read the Bible, we come upon these passages or some of the stories that are either difficult to understand or it's a topic that we don't wanna deal with. It's really hard to swallow. Like a lot of times it's the genocide passages, of course. Mm-hmm. And or similar things like that. What do we do when we encounter those passages? Yeah. There are also passages that are sometimes called, and the genocide fits into this, but passages called texts of terror. A lot of passages about different abuse situation, and [00:25:00] I won't go into all of those, but I'm sure a lot of us can come up with some things that mm-hmm. Can be triggering in the Bible that seem just really messed up and stuff like that. So I think what's important, first of all is we recognize the, the gut feeling, the awkwardness talk to the beginning about how I see humor in the Bible and I do, I think there are some things in the Bible that we should laugh at. It's actually hilarious. Tell us about what Jonah gets swallowed by a big fish. That's funny. You should be laughing. And it's hilarious that he wants this city destroyed and he's supposed to be a prophet of God and he's not doing his job description and stuff like that. So like. When it's funny, we should laugh and when it's not funny, when it's uncomfortable, we should be okay being uncomfortable. I, I remember when I did college ministry for a time, we talked about the story of, oh man, I can't remember if it's Eli, I think it's Elijah. [00:26:00] And when they make fun of him for being bald and he calls these, she bears to attack these 40 youths, and he, this kid would kid could not get over it. He's like, why is this in the Bible? This is ridiculous. And I just tried to help him. Yeah, let's feel that first. Let's feel that, oh boy, we got some emotions here. So step one, I think it's totally okay to feel those things and then we can do some digging. Again, it's that zooming out. Let's look at the context here. Let's look what's going on there. A lot of times I think some of these texts of terror or uncomfortable texts, um. Sometimes they're not as bad when we look at it through maybe a historical lens or something, but sometimes we can't just justify them really nice and neatly, like some of the stuff about genocide. So ultimately, I have to go back to Jesus because. Jesus is the ultimate expression of God. It is the best [00:27:00] lens into the divine that we've ever seen. It's through this person of Jesus. And so sometimes we got to use our Jesus magnifying glass and look over the scripture and say, that's awkward. I don't like that very much. This makes me, this triggers me. This is, uh, but we put Jesus over and say, but through Christ, we don't have to live like that. We can recognize that there. There are plenty of examples of what not to do in the Bible. Jesus calls us to a different way and Jesus shows us that some things that maybe people thought were really godly and divine at certain points were not. So at the end of the day when things make us uncomfortable, I say feel it. But then ultimately, let's just go back. What does Jesus say? And if Jesus words are kind of. Don't seem to jive with this other crazy stuff going on here. Let's just, let's follow Jesus over some of this, [00:28:00] this other uncomfortable things. Hmm. So it's probably not a satisfying answer, but that's kind of like the point, like we try too hard sometimes to wrap everything in a pretty bow, but sometimes we just can't. With the Bible, the Bible is complicated and that's what makes it powerful. It's not always so neat and tidy and doesn't always make you feel good. It is a like Christ. It is both human, fully human and fully divine. And in that there's some awkward tension. There are some, there are human emotions and human things that that bleed through the divine pages of scripture. I appreciate the honest answer and yeah, I think that was a great answer. It was just reading through the patriarchs and wow, you just wrap your head around how much they messed up. And that's not how God wanted us to live. That's just an example of God just lets [00:29:00] everybody see how these people messed up. But still, God used them in a mighty way. God still gave them grace and forgiveness and love and mercy. I was just on Twitter and that's a dangerous place is Christian Twitter. Oh my goodness. And there was a big thread about some people, they didn't believe that Jesus was the same God as the God of the Old Testament. They cut the line because they thought Jesus over here in the New Testament, his attribute seems so different than. The God of the Old Testament. I don't necessarily agree with that, but that was an interesting concept. That's how they dealt with those horrible stories. I'm just gonna just trust in Jesus and just believe in Jesus and throw everything else away. Yeah. That's a heresy in the second century that, um, yeah. You know, unfortunately haven't quite gotten rid of completely, but is that's what that's called still alive and, [00:30:00] yeah. Oh, that's what you call it. Okay. There's your little fun little historical theology trivia, but yeah, there's probably a word for it. But that goes into my next question is how do you study the Bible and read it and make sure that you're not slipping into some heretical teaching, because I personally know some people that they believe some stuff that's way off base that nobody else. And mainline Christianity believes in, but they're like quoting Bible verses and taking them outta context. How do we avoid going down that path? Yeah, yeah. I had a youth minister who used to joke that if you wanted to, he could justify kicking babies across the room from scripture. Like that was just his wild example because yeah, people can kind of justify the whole gambit of things. So I think now we talked about why it's important to study the Bible for yourself. [00:31:00] At the same time though, I think this living, breathing scripture. Is something that we must read through community. You can do your own work, do your own prep, but ultimately the Bible belongs to all of us. And so we need to read in community. And that can mean your pastors and teachers and your scholars. It can also mean your neighbor and your friend and your kids and your mom and your cousin from a couple states away. But it can also mean dead people, not like seance or whatever, but like, um-ing, you know, read these old preachers and read the church fathers and the church mothers and like, we got 2000 years of Christian history here. There's some wild stuff, but there's some good stuff too. So I say we read scripture in community and you come to your own conclusions. Don't just copy paste whatever Mr. X, Y, Z says, but. What do they [00:32:00] think? And when we start looking at, oh, Christians have kind of seemed to think this for a long time, probably a direction we should lean in. I don't know. I guess people could be wrong, but the way the spirit works I think is a lot of times through community. And it's a way to check, it's a checks and balance for ourselves. So I think that sometimes we can get a little, a little wild with our own interpretations, but we bring in other people. What do you think? Did you see this too? Is this accurate? Is this, does this fit in with historical context of first century Palestine? Or whatever kind of questions you want to ask community. So that's flesh and blood people, but that's also books and podcasts and all sorts of things. I just think we're made to be together. And honestly, when I studied Paul's view of spiritual formation for my thesis, I didn't get to dive into it too much, but what I kept coming across is spiritual formation is not a. You on your own [00:33:00] kind of thing. It is something that happens with people who are this great cloud of witnesses that is cheering you on and it's helping you out. So I think that's a great way to kind of check, check ourselves, and then of course, use your brain. Let's be logical here that scripture probably not actually talking about America because it was written 3000 years ago. I don't know. Thank you. Um, so, so stuff like that, we gotta use our brains. Yeah. I like when you talk about community, because I think, and I've seen this before people go off the rails, is that they're isolating themselves. Mm-hmm. They don't wanna go to church because they don't trust, they don't trust people that they've been hurt. But even if we can't drag ourselves to church just yet in our healing process, yeah. There are other ways to create community and checks and balances. So that's a really good point. We really don't want [00:34:00] to be that guy that started his own denomination on a couple bible verses. Yeah, we got plenty of denominations. I think we're set for a little bit, so let's just chill out for now. Yeah, that's crazy. So like if we're in a community, we're under our Bible teacher or a pastor or Sunday school class, what would be like a red flag that would put your antennas up? Hey, you may wanna check this out for this preacher teacher saying is not a good thing. Are there any like red flags that you would look for? I think arrogance is definitely a big red flag. Ooh, good one. And that is how you get into spiritual, spiritually abusive situations. Definitely. And what I mean by arrogance is people that are not willing to be corrected, not willing to admit the wrong, not willing to learn. I was privileged to have professors where I was getting my Bible degrees. People with [00:35:00] PhDs from the prestigious British universities who would listen to student comments and be like, that's really interesting. Or, heard it like that. Tell me more about that. And one of my Hebrew Bible professors spoke like nine languages. Most of those are dead ones. And still he's curious to know what these 20-year-old college students are thinking. Which is wild because he is way smarter than us. But he is. These guys were adopting this posture of, I can learn from anybody here. I want your perspective. And I could be wrong. We gotta have some things where we have a firm foundation and where we don't sway. We absolutely have to have those. There are some people these days that I think sort of lean too heavily into the wishy-washy. It depends on the day, what I'm feeling, cafeteria style Christianity. We can't do that. But we also can't go over here where it's, I figured it out when I was 30 years old, when I was 40 years old, and now I'm like, [00:36:00] done. I'm done learning. Got it right. I to be the only one to get it right. And that's how denominations start, right? Ooh, everybody else got it wrong all the time. Now I'm right. So that's dangerous. So let's learn from people who are themselves. Learners who are willing to be challenged and to ask questions and wanna know your take on things. I know from being in ministry settings that oftentimes I am the guy with the more Bible degrees than most people in the room. But then there'll be these 70-year-old church ladies who have lived this and they've been in the Bible their whole life. I can learn from them. Mm-hmm. They have something to say, even though they've never read the text in Greek. They have something to add to the conversation. Mm-hmm. So we need to be learners. I love that. That is so awesome and so very true. The Holy Spirit speaks to each of us individually and gives us different [00:37:00] lessons and we can share those lessons. Now, you as a scholarly person, you must have some favorite resources that you use to study the bible. Can you recommend some specific resources that are maybe easy to use? Yeah, there's a couple websites, Bible gateway, I mentioned that already. They have. Some free commentaries and bible encyclopedias and things kind of on the sidebar there. So as you're looking to scripture, you could glorify and study Bible or have access to chunks from different commentaries. And for a while, while I was doing some more preaching, I actually did the paid, there's a kind of a paid version that it was like five bucks a month or something really cheap like that. It just got access to more things so I can have the scripture here and then all my resources next to it. And that was handy. Bible hub.com is also another one. [00:38:00] Um, that one's especially good if you do wanna look at the language stuff, knowing that you're not a scholar, you can say, but what is that Greek word? And you can click on it and it will show you the definitions, show you other places in scripture it's used. You can kind of get a feel for that. So that's a really good one for people who are not, who don't know the languages or. Like me who always needed help with my Greek homework or something like that. So yeah, those come to mind. But man, like we are, we at our fingertips. There's a lot of good stuff out there. A lot of bad stuff, no doubt. But there are podcasts and all sorts of books and there's just, there's a lot of good stuff there. Wouldn't even know where to begin, just sort of thinking broadly. But I think Bible gateway, Bible hub, easy. Anybody can access those for free. And you don't necessarily need a giant library or really expensive commentary sets 'cause they're really expensive. Yeah. That's why my parents get me one commentary for my birthday and [00:39:00] for Christmas each year. And so in 50 years I'll have the full set or whatever. That's not true. That's, it'll actually probably be. I can't do the math however it takes to get 66 books. But anyway. Wow. All I had in bible college that we were allowed to have is Matthew Henry commentary, which is kind of on the dry side. Yeah. Most Bible professors would pass out hearing you say that. It's not bad stuff, but bad, but it's not, it's not easy to read it's thing, let's just say. Yeah. And we were allowed to read Weirs, BE'S books. It's a pretty good series about where I came from. John MacArthur's commentaries were like hearsay. Oh, okay. The Baptist didn't like the, at least the churches that I was in, they didn't like MacArthur's stuff, but, and I had the actual strong concordance. I still own that's, yeah, sure. So sort of a free way to get that, besides if you don't want to get a giant [00:40:00] volume. Yeah. I like to read the physical books too. Sure. Nothing, not knocking the physical. But yeah, if people are on a budget, yeah, people are on a budget and you can't go and buy those big, huge coffee table books. Or if you're near a Christian university, see if you can get a library card that's, they have tons of stuff. I can walk in there and there are a whole shelf of like Genesis commentaries or whatever. It could be information overload. But also I can, I'll pick up a couple different volumes of different perspectives and I'll read what they each have to say about the verse or chapter I'm dealing with and I can kind of synthesize a conclusion. And that's how you do it. Yeah. I'll also mention, I, we were allowed to. Listen on the radio, Jay Vernon McGee and yeah, he was definitely expository. He [00:41:00] would go verse by verse and go through the entire Bible verse by verse, which I thought was really good. And I don't agree with everything he said, but that's the way I learned a lot of stuff was through verse by verse radio program back in the day. Mm. I'm dating myself, aren't I? It's all good here. All good. No, we talked a lot about a bunch of different stuff. Is there anything about Bible study that we didn't talk about that you would like to mention? I know there's so much, uh, yeah, I just touched on it a little bit, but I kind of wanna bring it back. Look at different views than yours. If you are really charismatic, then look at something that's not quite charismatic, or if you are. I won't go. I'll skip all those differences. You know what? You are read some of the stuff that's a little different. Stuff that challenges you. That's how we grow. That's how we grow, [00:42:00] is to hear something a little different. And the thing is, you're not required to believe it. Right. You can just read it and at least know what they're saying. I know in my Christian upbringing, and not necessarily I was intentional, but I only knew my side of the argument. Or if I knew somebody else's argument, it was this straw man version that was just not accurate. And then I, you go to the big wide world and be like, oh wait, there are lots of different views. And those people are actually smart and they have things to say about this, but somebody else is the opposite and they're also a smart person. What's going on? It's just good to expose ourselves to different things. In most cases we could, we, you can choose your own boundaries and things like that. Mm-hmm. It doesn't mean if you're studying something in the Old Testament, you have to read the Jewish and the Muslim and the Mormon view of what. It doesn't mean you have to go there, but just check out some different things. Have your favorite commentaries. Do it, but every once in a while [00:43:00] peek into your, your local heretic and see what they have to say. I dunno, maybe not a heretic, somebody who's a little different. You, you, your istic. Yeah. Our last guest was talking about Calvinism and stuff, but yeah, doesn, excellent suggestion because I definitely was in my own camp for many years until I got out of my abusive situation and started looking into other views and I have since changed nothing major. I didn't change any major views, but I realized that okay, there are other Godly people. Now I see they can use scripture to defend their position too. And there's a little bit of wiggle room in there for sure. Sure. For different viewpoints. I went and did a study and looked at somebody else's view on a tertiary argument. Sure. Tertiary doctrine. It's not a doctrine of the faith, but [00:44:00] something that's very important and it's like, okay, I'm not gonna be judgmental. And that was hard for me to change my viewpoint. Yeah, yeah. But they gave me really great scriptural evidence. So yeah, that's kind of a sideline, but you made excellent point. But anyway, I appreciate you sharing all this valuable information and your view, viewpoint, and it's fascinating. Everybody has different answers for these questions. I've asked everybody the same questions. Right. And they're all giving me different answers, which I think that's very helpful. Oh yeah. Yeah. Very helpful. Yeah, getting people exposed to different things and again, like I am me and you are you, and we're different. And that's the point. Like we all come together with our different focuses and our different backgrounds and knowledge, and together we are the body of Christ. Amen. And that's beautiful. So tell the folks [00:45:00] how people can connect with you and you have resources and maybe if they wanna play stump the Bible teacher, they can email you. Yeah, you can find that all about me@jakedobern.com. D-O-B-E-R-E-N-Z as in zebra. And that's kind of my home base on the interwebs. If you do jake dovers.com/email, you can get on my email list that was mentioned earlier where I talk about. Funny stories from my life that have spiritual points, and I bring out spiritual points from that. And yeah, you can definitely contact me through social media or email, and that's all on my website there. So I'll let you track me down and tell me how wrong I am and all of that kind of stuff. That's fun. It comes with the territory, so totally okay with that. And then lastly, I do a bunch of work with Christian creatives, with Fiani [00:46:00] Media, and as was mentioned, I produce the Creatively Christian podcast. So I would love for you to check that out if that's kind of your thing, if that's your area. Yeah. You guys have a real great variety of guests on that show. It's not just one particular kind of art. You guys represent a lot of different ones, which is fun. Oh yeah. And we're trying to get more variety all the time. Awesome. Now. I don't usually have guests pray on the show, but would you pray for our listeners in their journey in the scriptures? Of course. Let's go ahead and pray. Heavenly God, we come to you in prayer on this podcast episode and we ask that whoever's listening now in the future, in a couple years, where wherever we are, that, that we can be receptive to how you speak to us through scripture and through our [00:47:00] communities that help us see scripture. Let the spirit guide us as we dive into this sacred but sometimes confusing and complicated documents. Lord, I ask that you give us the wisdom to be able to rightly divide your word and to remain faithful even when our own preferences might wanna lean in a different direction. Lord, thank you so much for the ministry of this podcast. We pray that people continue to have healing and continue to find themselves in a better place, both in the world and with you spiritually. In Jesus' name, amen. Amen. Thank you so much for coming on the show. God bless you. Sure thing. God bless you. Thank you for listening to the Wounds of the Faithful Podcast. If this episode has been helpful [00:48:00] to you, please hit the subscribe button and tell a friend. You could connect with us at DSW Ministries dot org where you'll find our blog, along with our Facebook, Twitter, and our YouTube channel links. Hope to see you next week.

Clement Manyathela speaks to Kgomotso Modise, who is an EWN Reporter as well as Matome Chiloane, who is the Gauteng MEC for Education and Sports to understand the challenges faced by parents whose children remain unplaced for the 2026 academic year. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

In Episode 402 of ReDream Education, I'm speaking directly to the parents, teachers, founders, and community leaders who feel the growing tension in modern education — and the growing call to do something about it. If you've sensed that the system is strained… If your child is struggling in ways you didn't expect… If your classroom feels heavier than it used to… If you're feeling pulled toward something new, but you're afraid to name it… This episode is for you. Because right now, education is redreaming itself, and every one of us is part of that shift. ⭐ In This Episode, I Share:

In this special episode, Tara sits down with her friend and collaborator Sarah Habib from The Calm Caterpillar to share some exciting news—you're hearing it here first! Together, they've written a brand-new book, The Mindfulness Guide for Neurodivergent Learners, and this conversation takes you behind the scenes of how it came to life and why it's so needed. This episode is a must-listen for educators, therapists, and parents who want practical, neurodiversity-affirming strategies to support regulation, transitions, and connection—without compliance-based approaches. About the Book The Mindfulness Guide for Neurodivergent Learners is a 90-page, full-color, action-oriented guide designed to be: Easy to read and visually supportive Practical and immediately usable in classrooms and homes Grounded in neurodiversity-affirming, non-compliance-based practices The book includes: Real classroom photos and examples Scripts you can actually use Visual supports and calming strategies QR codes for free downloadable resources Tools for co-regulation, not just "self-regulation" Ideas for supporting transitions, calm corners, sensory needs, and deep interests What You'll Hear in This Episode How the idea for the book started (spoiler: it began with a simple message ☺️) Why regulation is the foundation for learning, connection, and communication The importance of modeling regulation strategies as adults Why mindfulness strategies should be practiced in a regulated state How to move away from token boards and "earning" regulation tools Using deep interests (like favorite characters) to support transitions and engagement Real-life classroom examples that actually worked Why consistency across home, school, and childcare matters so much The difference between compliance-based approaches and compassionate, child-centered ones A Big Takeaway This book isn't about quick fixes. It's about: Modeling Consistency Trust And honoring how neurodivergent learners experience the world As Tara and Sarah emphasize, slow burns are okay—real change takes time, repetition, and relationship. Special Listener Bonus Podcast listeners get 15% off the book!

John Maytham is joined now by Bronagh Hammond, Head of Communications at the Western Cape Education Department, to unpack how the WCED plans to meet this ambitious deadline and what parents need to know – by placing all learners at schools within the first 10 days of the academic year. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

"Referring patients to audiology early on has shown dramatic reduction in hearing loss or complications because the audiologist can really see where were they at before they started chemotherapy, where were they at during, if they get an audiogram during their treatment. And then after treatment, it's really important for them to see an audiologist because this is really a survivorship journey for them. And as nurses, the 'so what': We are the first line of defense," ONS member Jennessa Rooker, PhD, RN, OCN®, director of nursing excellence at the Tampa General Hospital Cancer Institute in Florida, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about ototoxicity in cancer care. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 9, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the management of ototoxicity after chemotherapy treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ Cancer Symptom Management Basics series ONS Voice articles: Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Carboplatin Oncology Drug Reference Sheet: Oxaliplatin FDA Approves Sodium Thiosulfate for Cisplatin-Associated Ototoxicity in Pediatric Patients ONS book: Clinical Manual for the Oncology Advanced Practice Nurse (fourth edition) American Cancer Society resources: 4 Causes of Hearing Problems for Cancer Survivors Cancer Survivors Network American Speech-Language-Hearing Association (ASHA) Hearing Loss: An Under-Recognized Side Effect of Cancer Treatment Embedded Ear Care: Audiology on the Cancer Treatment Team American Society of Clinical Oncology (ASCO) Annual Meeting abstract: Innovative Infusion Center Assessments of Chemotherapy-Induced Neurotoxicities: A Pilot Study Supporting Early and Routine Screenings as Part of Survivorship Programs Children's Oncology Group supportive care endorsed guideline: Prevention of Cisplatin-Induced Ototoxicity in Children and Adolescents With Cancer: A Clinical Practice Guideline Ear and Hearing article: Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment International Ototoxicity Management Group (IOMG) IOMG Wikiversity page Shoebox hearing assessments World Health Organization initiative: Make Listening Safe To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "At different pitches, the eardrums move faster or slower, signaling the inner ear, or the cochlea—the thing that looks like a snail in the pictures. The cochlea has fluid and hair cells inside of it that receive movements from the eardrum. The hair cells change the movement into electrical signals that actually go to the auditory nerves or the cranial nerve VIII." TS 2:15 "Ototoxicity is an umbrella term for some sort of exposure to a toxin that causes damage to the inner ear. These toxins can be in the environment, such as loud or different noises, or they can be from medications, including antibiotics or commonly cancer treatments, such as radiation chemotherapy. Some common chemotherapies can be platinum-based chemotherapies like cisplatin or carboplatin. And then what patients are experiencing if they have ototoxicity can be hearing loss." TS 3:15 "The hypothesized mechanism of action is that the chemicals like the platinum compound in cisplatin … that platinum compound travels through our bloodstream. Since chemotherapy is systemic, it'll go to the inner ear, and it gets stuck there by binding to the cellular DNA in that cochlea, or that snail-looking image. That initiates the release of the reactive oxygen species, which are really trying to help clean it out, but releases such high levels that it ends up causing damage to those inner ear hairs. These inner ear hairs cannot regenerate themselves, so then they're permanently damaged. And remember we said that those hairs send electrical signals to the brain that recognize sound. So that function is permanently gone once those hair cells are damaged." TS 7:10 "I definitely think this is a huge interdisciplinary collaborative effort. As nurses and advanced providers, we're assessing and providing education. Our medical oncologists are doing those dose modifications and submitting those audiology referrals. The radiation oncologists are very important to know about this—maybe dose localization awareness. Maybe they do some changes with the doses. And then our audiologists and [ear, nose, and throat physicians], they can do that diagnostic confirmation and any rehabilitation measurements and really monitor them throughout their journey as well. And nurse navigators play a huge part in making sure those patients get those referrals, because a lot of the time the audiologists aren't in the cancer clinic, so they may have to go to another location or may need help coordinating with all their appointments that they have." TS 22:28 "We had a really innovative way of monitoring the hearing that a couple other studies have also tested. It's a remote point-of-care hearing screen. It was on [a tablet] with calibrated headphones. And then it's a paid-for subscription to an audiology testing platform. … Myself, along with a couple of other nurses, were trained how to use this testing device with the tablet and the headphones and the software program. And it was a quick down-and-dirty portable hearing assessment for patients. So anyone who was new to cisplatin, never gotten cisplatin treatment before, was enrolled into the study, and they received a hearing test every time that they came for chemo, and we gave it to them during their hydration." TS 28:59  

Dr. Michael Barla is an early childhood educator and former higher‑ed faculty member who now works at the Anchor Center for Blind Children in Denver. In 2024, he completed a residential fellowship at the Clyfford Still Museum, where he designed a sensory‑based translation of a Clyfford Still painting for a young child with a visual impairment.Jen Taylor is a teacher of students with visual impairments. She began her career in East Texas, spent several years at the Anchor Center, and now works in the Cherry Creek School District. Jen collaborated with Michael on conceptualizing and designing the multisensory translation of the artwork.Taylor Kingsbery is the parent of Miko, the toddler who explored Michael's translated artwork. Taylor brings a powerful perspective on accessibility, representation, and what it means to co‑create environments where disabled children can experience belonging and opportunity.This episode explores what it means to translate fine art—not simply replicate it—for young children with visual impairments. Dr. Michael Barla shares how his residency at the Clyfford Still Museum evolved into a hands‑on project: reimagining a Clyfford Still painting (pH‑914) as a fully sensory experience for Miko, a two‑year‑old who is blind.With deep collaboration from VI teacher Jen Taylor and insight from Miko's mom Taylor Kingsbery, the project transformed color, texture, line, and movement into elements children can feel, hear, and explore with their whole bodies. We follow Miko's visit to the museum—feet first, face pressed close, mapping the artwork from every angle—and learn how sensory access opens doors to representation, identity, and belonging.The conversation expands from art to universal design, rightful presence, and why inclusion has to begin at the design stage—not as an afterthought. The guests remind us that co‑creation with families and communities is essential if we want places like museums, classrooms, and public spaces to welcome everyone.Complete show notes and transcript: https://mcie.org/think-inclusive/how-museums-can-support-young-learners-with-visual-impairment-1316/

This year-in-review episode looks back at how AI reshaped conversations about teaching and learning, and moved from curiosity to classroom reality. This episode reflects on what educators learned about moving beyond compliance toward mastery, why students often follow rules better than they innovate, and how AI can support feedback, reflection, and trust. The conversation surfaces lessons about systemic thinking, place-conscious learning, and digital portfolios that show growth—offering a clearer, more grounded path forward for teaching in an AI-shaped future. Related Channel: ISTE Radio | Podcast Listen to all 2025 Mic Drop Episodes Related ISTE Books: Today's Learners, Tomorrow's Leaders | Get the Book-Putting Out Fires | The National Park Classroom | Edtech for Multilingual Learners | What the Tech? | AI for School Leaders | Available at ISTE.org

learn how to turn a verb into its future tense with this video conversation

In this episode of the Getting Smart Podcast, Tom Vander Ark sits down with Diane Tavenner, founder and CEO of Futre, and Marshawn Brown, a student user of the platform. Together, they discuss how Futre empowers students to explore diverse career pathways with transparency and dignity. From personalized career exploration and work-based learning integration to long-term tools for student success, this conversation reimagines the mission of education. Learn how schools can support students in navigating post-secondary options and preparing for meaningful, purpose-driven futures. Outline (00:00) Introduction to Futre Platform (09:02) Career Discovery and Exploration (13:33) Work-Based Learning Integration (22:35) Student Experience and Recommendations Links Read the full blog here Watch the full video here LinkedIn Futre Kairos Academies  

What does spill the beans really mean? In this quick ESL lesson, you'll learn the meaning, how native speakers use it, and how to sound natural when talking about secrets and surprises. Perfect for intermediate English learners who want to understand idioms without confusion.Tags / Hashtags:English idioms, ESL podcast, learn English fast, English expressions, ESL listening#ESL #EnglishIdioms #LearnEnglish #EnglishPodcast #SpillTheBeans

Matthew Mahavongtrakul shares about active learning that engages all learners on episode 603 of the Teaching in Higher Ed podcast. Quotes from the episode You don’t need to change your entire course tomorrow. What is one simple thing that you can do that will push you on the path? – Matthew Mahavongtrakul “The number one kind of piece of pushback that I get from faculty is I just simply cannot cover everything.” – Matthew Mahavongtrakul “I think at the crux of it, it is the shift in mentality between us as being, as we say, the sage on the stage to being a facilitator in the classroom.” – Matthew Mahavongtrakul Resources UC Irvine Division of Teaching Excellence & Innovation's Active Learning Institute Stephen Brookfield Todd Zakrajsek You Care About It, Do It in Class: Why faculty members need to shift the balance of class time from first exposure to skills practice Why Students Resist Learning with Anton Tolman on Episode 171 Notsu Notes Lily Abadal's workbook, outlining her process of having students write a research paper throughout her entire class Bluesky post of Andrea Kaston Tange sharing about her reading scenario experimentation POD Network Conference

"We proposed a concept to the American Society of Clinical Oncology (ASCO), recognizing that extravasation management requires significant interdisciplinary collaboration and rapid action. There can occasionally be uncertainty or lack of clear guidance when an extravasation event occurs, and our objective was to look at this evidence with the expert panel to create a resource to support oncology teams overall. We hope that the guideline can help mitigate harm and improve patient outcomes," Caroline Clark, MSN, APRN, AGCNS-BC, OCN®, EBP-C, director of guidelines and quality at ONS, told Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS®, VA-BC, oncology clinical specialist at ONS, during a conversation about the ONS/ASCO Guideline on the Management of Antineoplastic Extravasation. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 2, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the management of antineoplastic extravasation. Episode Notes  Complete this evaluation for free NCPD. ONS/ASCO Guideline on the Management of Antineoplastic Extravasation ONS Podcast™ episodes: Episode 391: Pharmacology 101: Antibody–Drug Conjugates Episode 335: Ultrasound-Guided IV Placement in the Oncology Setting Episode 145: Administer Taxane Chemotherapies With Confidence Episode 127: Reduce and Manage Extravasations When Administering Cancer Treatments ONS Voice articles: Access Devices and Central Lines: New Evidence and Innovations Are Changing Practice, but Individual Patient Needs Always Come First New Extravasation Guidelines Provide Recommendations for Protecting Patients and Standardizing Care Standardizing Venous Access Assessment and Validating Safe Chemo Administration Drastically Lowers Rates of Adverse Venous Events This Organization's Program Trains Non-Oncology Nurses to Deliver Antineoplastic Agents Safely ONS books: Access Device Guidelines: Recommendations for Nursing Practice and Education (fourth edition) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) ONS courses: Complications of Vascular Access Devices (VAD) and IV Therapy ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ ONS Oncology Treatment Modalities Clinical Journal of Oncology Nursing articles: Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center Standardized Venous Access Assessment and Safe Chemotherapy Administration to Reduce Adverse Venous Events Oncology Nursing Forum article: Management of Extravasation of Antineoplastic Agents in Patients Undergoing Treatment for Cancer: A Systematic Review ONS huddle cards: Antineoplastic Administration Chemotherapy Immunotherapy Implanted Venous Port ONS position statements: Administration (Infusion and Injection) of Antineoplastic Therapies in the Home Education of the Nurse Who Administers and Cares for the Individual Receiving Antineoplastic Therapies ONS Guidelines™ for Extravasation Management ONS Oncologic Emergencies Learning Library ONS/ASCO Algorithm on the Management of Antineoplastic Extravasation of Vesicant or Irritant With Vesicant Properties in Adults American Society of Clinical Oncology (ASCO) Podcast: Management of Antineoplastic Extravasation: ONS-ASCO Guideline To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "The focus of this guideline was specifically on intravenous antineoplastic extravasation or when a vesicant or an irritant with vesicant properties leaks out of the vascular space. This can cause an injury to the patient that's influenced by several factors including the specific drug that was involved in the extravasation, whether it was DNA binding, how much extravasated, the affected area, and individual patient characteristics." TS 1:48 "The panel identified and ranked outcomes that mattered most with extravasation. Not surprising, one of the first was tissue necrosis. Like, 'How are we going to prevent tissue necrosis and preserve tissue?' The next were pain, quality of life, delays in cancer treatment: How is an extravasation going to delay cancer treatment that's vital to the patient? Is an extravasation also going to result in hospitalization or additional surgical interventions that would be burdensome to the patient? ... We had a systematic review team that then went in and summarized the data, and the panel applied the grading of recommendations, assessment, development, and evaluation (GRADE) criteria, grading quality of evidence and weighing factors like patient preferences, cost, and feasibility of an intervention. From there, they developed their recommendations." TS 7:35 "The panel, from the onset, wanted to make sure we had something visual for our readers to reference. They combined evidence from the systematic review, other scholarly sources, and their real-world clinical experience to make this one-page supplementary algorithm. They wanted it to be comprehensive and easy to follow, and they included not only those acute management steps but also guidance on 'How do I document this and what are the objective and subjective assessment factors to look at? What am I going to tell the patient?' In practice, for use of that, I would compare it to your current processes and identify any gaps to inform policies in your individual organizations." TS 16:34 "The guidelines don't take place of clinician expertise; they're not intended to cover every situation, but a situation that keeps coming up that we should talk about as a limitation, is we're seeing these case reports of tissue injury with antibody–drug conjugate extravasation. There's still not enough evidence to inform care around the use of antidotes with those agents, so this still needs to be addressed on a case-by-case basis. We still need publication of those case studies, what was done, and outcomes to help inform direction." TS 19:24 "Beyond the acute management is to ensure thorough documentation regarding extravasation. Whether you're on electronic documentation or on paper, are the prompts there for the nurse to capture all of the factors that should be captured regarding that extravasation? The size, the measurement, the patient's complaints. Is there redness? Things like that. And then within the teams, everyone should know where to find that initial extravasation assessment so that later on, if they're in a different clinic, they have something to go by to see how the extravasation is healing or progressing. ... I think there's an importance here, too, to our novice oncology nurses and their preceptors. This could be anxiety-provoking for the whole team and the patient, so we want to increase confidence in management. So, I think using these resources for onboarding novice oncology nurses is important." TS 22:34

What should K-2 teachers know about teaching phonemic awareness, phonics, handwriting, and more? Teacher and author Amie Burkholder gives us practical tips in this quick and powerful episode! Get the show notes here: http://themeasuredmom.com/episode221Get the free Letter Sounds Game: https://www.themeasuredmom.com/tmm_optin/letter-sounds/ Sign up for my free masterclass, 5 Essential Steps to Reach All Readers. Get my book, Reach All Readers! Looking for printable resources that align with the science of reading? Click here to learn more about our popular and affordable membership for PreK through 3rd grade educators.Connect with me here! Blog Instagram Facebook Twitter (X)

Shingles is a reactivation of the varicella‑zoster virus and poses a substantial burden, particularly for older adults and immunocompromised individuals. During this podcast, experts discuss the evolving epidemiology of shingles, distinguish between typical and atypical presentations across dermatologic, neurologic, and ophthalmic domains. Learners will gain insights into prevention strategies including vaccination and timely antiviral therapy to reduce complications. Claim CE and MOC credit at: https://bit.ly/4qkvOPU

Do you ever stop mid-sentence and think, “Is this the right word?”You're not alone — and it's not your fault.In this 10-minute ESL podcast episode, we break down the top 10 most confusing English word pairs for ESL learners and explain them in a way that finally makes sense.In this episode, you'll learn:✔️ The meaning of each word✔️ The part of speech (noun, verb, adjective, etc.)✔️ Clear example sentences you can use immediately✔️ Simple rules to stop mixing these words up in real conversationsWe cover common problem pairs like:say vs tellhear vs listenmake vs doborrow vs lendbring vs takelose vs loose…and more.This episode is perfect for intermediate ESL learners (B1–B2) who want to:speak more confidentlyavoid common English mistakessound more natural in everyday and workplace conversations

Learn More About CharacterStrong:  Access FREE MTSS Curriculum Samples Request a Quote Today! Learn more about CharacterStrong Implementation Support Visit the CharacterStrong Website

"They [monoclonal antibodies] are able to cause tumor cell death by binding to and blocking to necessary growth factor signaling pathways for tumor cell survival. That's going to be dependent on the target of the antibody, but I'll give an example of epidermal growth factor, or EGFR. This is overexpressed in several different kinds of cancers where activation of this growth factor increases the amount of proliferation and migration of cancer cells. So, if we bind to it and block to it, then that would help halt these pathways and stop cancer cell growth," Carissa Ganihong, PharmD, BCOP, oncology and bone marrow transplantation clinical pharmacist at Hackensack University Medical Center in New Jersey, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about monoclonal antibodies. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) (including 45 minutes of pharmacotherapeutic content) by listening to the full recording and completing an evaluation at courses.ons.org by December 26, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge in the history of, the mechanism of action of, and the use of monoclonal antibodies in the treatment of cancer.  Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 391: Pharmacology 101: Antibody–Drug Conjugates Episode 383: Pharmacology 101: Bispecific Antibodies Episode 375: Pharmacology 101: VEGF Inhibitors Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role Episode 283: Desensitization Strategies to Reintroduce Treatment After an Infusion-Related Reaction Episode 275: Bispecific Monoclonal Antibodies in Hematologic Cancers and Solid Tumors ONS Voice articles: An Oncology Nursing Overview of Biosimilars Make Subcutaneous Administration More Comfortable for Your Patients Oncology Nurses' Role in Translating Biomarker Testing Results Reduce Chair Time by as Much as 16 Minutes by Priming IVs With Drug Shorter Administration Times Still Require High-Acuity Care The Names of Targeted Therapies Give Clues to How They Work ONS Voice drug reference sheets: Datopotamab deruxtecan-dlnk Enfortumab vedotin Margetuximab-cmkb Mirvetuximab soravtansine-gynx Nivolumab and hyaluronidase-nvhy Nivolumab and relatlimab-rmbw Pembrolizumab and berahyaluronidase alfa-pmph Retifanlimab-dlwr ONS book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) ONS course: ONS Fundamentals of Chemotherapy and Immunotherapy Administration™ Clinical Journal of Oncology Nursing articles: Bolusing IV Administration Sets With Monoclonal Antibodies Reduces Cost and Chair Time: A Randomized Controlled Trial Management of Immunotherapy Infusion Reactions Nurse-Led Grading of Antineoplastic Infusion-Related Reactions: A Call to Action Safety and Adverse Event Management of VEGFR-TKIs in Patients With Metastatic Renal Cell Carcinoma Oncology Nursing Forum articles: Administration of Subcutaneous Monoclonal Antibodies in Patients With Cancer Depressive Symptoms and Quality of Life Associated With the Use of Monoclonal Antibodies in Breast Cancer Treatment ONS huddle cards: Bispecifics Checkpoint Inhibitors Monoclonal Antibodies Other ONS resources: Biomarker Database Bispecific Antibodies video Patient Education Sheets Antibodies article: A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy Cureus article:  A Comprehensive Review of Monoclonal Antibodies in Modern Medicine: Tracing the Evolution of a Revolutionary Therapeutic Approach Association of Cancer Care Centers (ACCC) homepage Cancer Immunology, Immunotherapy article: Therapeutic Antibodies in Oncology: An Immunopharmacological Overview Drugs@FDA package inserts Future Oncology article: Biosimilars: What the Oncologist Should Know Hematology/Oncology Pharmacy Association homepage National Comprehensive Cancer Network homepage Network for Collaborative Oncology Development and Advancement (NCODA) subcutaneous therapy article Oncolink: Side Effects of Immunotherapy World Health Organization: New International Nonproprietary Names (INN) Monoclonal Antibody Nomenclature Scheme To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Prior to monoclonal antibodies, all we really had were these toxic chemotherapies or toxic radiation, so it was recognized how great it would be if we could have a treatment that was much more specific to the tumor cells and have agents that have less toxicities. These advancements in monoclonal antibody production began in the 1980s. ... Eventually, we had the first monoclonal antibody that was approved by the U.S. Food and Drug Administration (FDA) for an oncologic indication, rituximab." TS 4:14  "Nowadays, we do have treatments that are also considered tumor-agnostic. This is when a patient has a certain biomarker, then that treatment can be given and FDA approval was given, regardless what type of tumor the patient has. We typically see these kinds of tumor-agnostic therapies more so in patients who have recurrent or advanced diseases in solid tumors. One monoclonal antibody example that comes to mind is dostarlimab. That's a checkpoint inhibitor that's approved for patients who are deficient in mismatch repair mechanism." TS 23:48 "Our immune system constantly has this surveillance system and it's able to recognize foreign pathogens, abnormal cells, and even precancerous cells. And they're able to eliminate them before they become cancerous. But on the flip side, one of the regulatory mechanisms that we have so our immune system doesn't attack itself is the presence of checkpoints. When these checkpoints bind to their ligands, this can then act as an off switch so that, again, our immune system is not going to attack itself. But then the tumor cells can take advantage of this and actually use this mechanism to evade the immune system. So, when we're giving a checkpoint inhibitor, now we're removing that off switch. As a consequence, common adverse effects can include things like immune mediated adverse events. These most commonly affect the skin, gastrointestinal tract, and liver. Essentially, this can cause any '-itis' you can think of." TS 26:36 "Looking at strategies to prevent infusion reactions, one example is the use of premedication. If premedication is recommended, this typically includes any combination of antipyretics, which is typically acetaminophen. Antihistamine, which is typically an H1 antagonist like diphenhydramine. Although, there could be cases where we want to substitute this agent because maybe the patient has been tolerating therapy okay, and they're having a lot of side effects. So, we might use a second-generation antihistamine in some cases. The premedication may be given with or without some kind of steroid, whether that's methylprednisolone, hydrocortisone, or dexamethasone." TS 29:53 "We tend to think of monoclonal antibody usage to be primary oncology, but that's not really the case. The first monoclonal antibodies that were developed were not for oncologic indications, they were for transplant indication for cardiac indication. So, they're really diversely utilized across all specialties and medicines. We have monoclonal antibodies for hyperlipidemia, for neurology, for rheumatology, so the uses are so very expansive across all specialties." TS 41:01

Stephen answers listeners' questions.-------------------------------------------------------€10 off becoming a yearly supporter  = december2025www.send7.org

Kgomotso Modise speaks to Steve Mabona, who is the Spokesperson for the Gauteng Education Department to get an update on the placement of learners who are still waiting for admission for the 2026 school year. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

"The thought of recurrence is also a psychosocial issue for our patients. They're being monitored very closely for five years, so there's always that thought in the back of their head, 'What if the cancer comes back? What are the next steps? What am I going to do next?' It's really important that we have conversations with patients and their families about where they're at, what we're looking for, and reassure them that we'll be with them during this journey and help them through whatever next steps happen," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer survivorship considerations for nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by December 19, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to survivorship nursing considerations for people with prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 390: Prostate Cancer Treatment Considerations for Nurses Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: APRNs Collaborate With PCPs on Shared Survivorship Care Models Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors Nursing Considerations for Prostate Cancer Survivorship Care Regular Physical Activity and Healthy Diet Lower Risk of All-Cause and Cardiac Mortality in Prostate Cancer Survivors Sexual Considerations for Patients With Cancer Sleep Disturbance Is Part of a Behavioral Symptom Cluster in Prostate Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing articles: A Patient-Specific, Goal-Oriented Exercise Algorithm for Men Receiving Androgen Deprivation Therapy Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Prostate Cancer: Survivorship Care Case Study, Care Plan, and Commentaries The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: A Qualitative Exploration of Prostate Cancer Survivors Experiencing Psychological Distress: Loss of Self, Function, Connection, and Control Identification of Symptom Profiles in Prostate Cancer Survivors Sleep Hygiene Education, ReadiWatch™ Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia for People With Prostate Cancer Understanding Men's Experiences With Prostate Cancer Stigma: A Qualitative Study Other ONS resources: Late Effects of Cancer Treatment Huddle Card Survivorship Care Plan Huddle Card Survivorship Learning Library American Cancer Society (ACS): Living as a Prostate Cancer Survivor ACS prostate cancer survivorship studies To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the most common late side effects [are] urinary, bowel, and sexual dysfunction issues. For urinary effects, it can include urgency and frequency, some incontinence, or a weak or slow urine stream that frequently bothers the patient after treatment. Bowel effects can happen such as constipation, diarrhea, or inflammation of the rectum, which can lead to bleeding or mucus discharge. And then erectile dysfunction is another side effect that patients with prostate cancer often deal with and have to work with their physicians on, depending on what they want with that function. Fatigue, lymphedema, and skin changes can also occur after treatment." TS 1:40 "If we can catch [prostate cancer] and take care of it at an early stage, overall survival is about 90%. If the disease is localized, it's 99%. If we can take out the prostate, radiate the prostate, we can do something with that—localized, 99% survival rate. If there's regional metastasis, it's about 90%. And if there's distant metastasis, it's about 30% survival." TS 3:55 "Prostate cancer recurs in about 20%–30% of patients within the first five years of initial treatment. ... There's not a lot of research out there that shows what can reduce risk, but what has been shown to be effective is regular exercise, quitting smoking, and eating a healthy diet. ... It's really important for our patients to understand the importance of having follow-up visits so that we can catch a recurrence quickly instead of waiting years down the road. Prostate cancer is usually a slow-growing disease, so if we can pick it up quickly in those revisits, we can start another treatment for the patient." TS 6:00 "Sexuality is not something many people are comfortable discussing, but we really need to talk with patients and let them know that this is normal. It is normal that you may have some sexual dysfunction. It's normal that you may not feel the way you did before. Talk to us about it, let us know where you're at, let us know what your goals are, because there are a lot of things we can do. There are medications we can use for impedance. There are devices and implants available to help the patient to support them and give them whatever their goal is for their sexuality." TS 9:41 "Providing survivorship care plans are important for these patients—something that can be sent off to everyone else that's caring for that patient. You have your primary care physician, urologist, oncologist, the oncology nurse, maybe a navigator, and [others] who are looking into this patient. So, giving that patient a survivor care plan and putting it with their files to include a summary of the treatment received, because most of the time a patient is not going to remember exactly what they received. A suggested schedule for follow-up exams—so again, if a primary care provider is not used to dealing with a patient with prostate cancer, they have something to go off of. A schedule of other tests they may need in the future including screening for other types of cancer. Are they a smoker? Do they need lung screening? Do they need any other screenings related to types of cancers? And then a list of possible late or long-term side effects." TS 15:16 "I think a lot of people know about the long-term sexual effects, but what we don't really talk about is the effect that it has on the patient's self-image. How they define themselves, how they look, their body image, their self-image. It's really important that we continue to discuss it with patients and make them comfortable when discussing their sexuality and their goals for sexuality. They may be having these self-image issues after treatment that they're just not telling us about and that can affect their quality of life." TS 18:38

Join endocrinology experts Sara MacLeod and Shannon Idzik as they explore the science and strategy behind effective obesity care, offering practical, evidence-based insights clinicians can apply right away. From navigating treatment options like lifestyle interventions, medications and surgery to fostering stigma-free, patient-centered conversations, this episode delivers real tools for improving outcomes. Whether you're new to obesity management or looking to enhance your clinical approach, this discussion will inspire confidence and compassion in your practice. Objectives Evaluate clinical trial data providing evidence for the current obesity treatment landscape. Examine the pharmacotherapies for treatment of obesity. Summarize lifestyle factors and behavior change options available for people living with obesity, addressing stigma and bias. Develop a treatment plan for patients living with obesity that addresses their individual comorbidities, clinical risks and personal goals. Learners may claim CE credit for this program through Dec. 31, 2026, by participating in the full multi-module Clinical Advantage: Endocrinology Certificate for Advanced Practice Providers program available here. A participation code will be provided at the end of the podcast — make sure to write this code down. Once you have listened to the podcast and have the participation code, return to this activity in the AANP CE Center. Click on the "Next Steps" button of the activity and: Enter the participation code that was provided. Complete the posttest. Complete the other modules of the Clinical Advantage: Endocrinology Certificate for Advanced Practice Providers program. Complete the overall program evaluation. This activity is supported by independent educational grants from Ascendis Pharma Inc., Novo Nordisk Inc., and Xeris Pharmaceuticals, Inc.

Protect your family with our 1-minute free parent quiz https://www.smartsocial.com/newsletterJoin our next weekly live parent events:  https://smartsocial.com/eventsEpisode Summary:In this episode of the SmartSocial.com podcast, host Josh Ochs talks with Dr. Bernard Frost, Assistant Superintendent for Curriculum and Instruction in Orangeburg, SC. They discuss the challenges and successes of integrating AI in lesson planning, managing screen time, and addressing social media issues among students. The episode explores how rural and urban districts share similar digital safety challenges and emphasizes the importance of effective communication between parents, teachers, and school staff. Dr. Frost also shares insights on using AI in education, managing screen time addiction, and ensuring students' online safety.Become a Smart Social VIP (Very Informed Parents) Member: https://SmartSocial.com/vipDistrict Leaders: Schedule a free phone consultation to get ideas on how to protect your students in your community https://smartsocial.com/partnerDownload the free Smart Social app: https://www.smartsocial.com/appdownloadLearn about the top 190+ popular teen apps: https://smartsocial.com/app-guide-parents-teachers/View the top parental control software: https://smartsocial.com/parental-control-software/The SmartSocial.com Podcast helps parents and educators to keep their kids safe on social media, so they can Shine Online™

In this Episode of the OT Schoolhouse Podcast, Jayson Davies welcomes Dr. Jaime Hunter and Dr. Kaisa Syväoja from The College of St. Scholastica to discuss how OT practitioners can utilize grants to advocate for mental health services in schools. Learn how grants can expand your OT practice beyond traditional tier three services, whether you're looking to fund a sensory room, provide professional development, or implement a school-wide mental health initiative.This conversation demystifies the grant-writing process, offers practical tips for finding and applying for grants at the federal, state, and local levels, and highlights the power of collaboration to sustain impact beyond the grant period—making this a must-listen for OTs ready to expand their role and amplify OT's value in schools.Listen now to learn the following objectives:Learners will identify how to apply for grants (both small and large) to expand mental health services and other OT initiatives within school settings.Learners will understand how to effectively advocate for occupational therapy's role in supporting mental health at all tiers (especially tiers 1 and 2) within school-based practice.Learners will develop strategies for creating sustainable partnerships and programs that can continue beyond initial grant funding by demonstrating OT's value to school administrators and staff.Thanks for tuning in! Thanks for tuning into the OT Schoolhouse Podcast brought to you by the OT Schoolhouse Collaborative Community for school-based OTPs. In OTS Collab, we use community-powered professional development to learn together and implement strategies together. Don't forget to subscribe to the show and check out the show notes for every episode at OTSchoolhouse.comSee you in the next episode!

In this episode, I sit down with Dr. Sarah Frampton, who conducts research on, amongst other things, improving how we teach, learn, and organize information using behavior-analytic strategies. We explore her career journey, her research on graphic organizers and the Cover, Copy, Compare (CCC) strategy, and the broader implications for stimulus equivalence, educational technology, and effective teaching. In This Episode, You'll Learn: How Sarah's unconventional path led her from economics and psychology into Applied Behavior Analysis (ABA). Why note-taking and structured learning strategies, like CCC, matter for retaining and applying complex information. How stimulus equivalence principles can enhance learning beyond direct instruction. Insights from Sarah's research combining CCC with graphic organizers, including practical takeaways for educators and learners (see Frampton, Vesely and Jackson, 2025). How visual learning tools and educational technology can improve engagement and retention. Strategies for training learners to use these approaches independently and effectively. Highlights From Our Conversation: Sarah's Path Into ABA Sarah shares how a thesis requirement and a Craigslist job posting led her to ABA, including formative experiences working with Dr. Alice Shillingsburg at the Marcus Autism Center. These experiences sparked her interest in efficient, broadly applicable learning strategies. Why Note-Taking Strategies Matter We discuss the value of graphic organizers and the Cover, Copy, Compare (CCC) strategy: Graphic organizers visually display relationships between concepts. CCC is a structured, active-response method that strengthens memory, similar to flashcards. Sarah emphasizes how behavior-analytic techniques can support higher-order thinking processes often considered "cognitive." CCC and Stimulus Equivalence Sarah walks through stimulus equivalence with clear examples, showing how teaching certain relations can produce broader learning without direct instruction. She also highlights a study where CCC and graphic organizers helped learners prepare for tests—even under intentionally challenging conditions. Graphic Organizers in Action Key findings from Sarah's research: Learners who drew more structured organizers performed better. Teaching organizer use during test conditions did not hinder performance. Visualizing relationships among stimuli predicted task success. Training Learners to Use These Strategies Sarah outlines her training sequence, including pre-tests, video instruction, practice with familiar material, and application to abstract stimuli. A core goal was strategy generalization—ensuring learners could apply CCC to new material independently. Fig. 1 from Frampton, et al. (2025) Fig. 2 from Frampton, et al. (2025) Research Findings Most participants quickly mastered abstract relations and passed post-tests after brief training. Notably, all participants used the CCC strategy—some even more meticulously than required. Educational Technology, Engagement, and Mediation Participants reported the educational technology intervention was easy to use and helpful, contrasting with high dropout rates in similar studies. Sarah also describes how participants naturally used private verbal behavior, such as naming stimuli or creating stories, to aid learning. Visual Learning Tools in ABA We discuss the broader application of visual supports—graphic organizers, flashcards, handwriting—and their role in enhancing learning efficiency for both adults and children with autism. Looking Ahead Sarah previews her upcoming presentation at the Verbal Behavior Conference, covering generative learning and assessment tools. We also explore how collaboration and community can reduce burnout and increase long-term job satisfaction in ABA in the "advice for the newly-minted" segment. Resources & Links Session 287: BiDirectional Naming with Caio Miguel. Session 80: Verbal Behavior and Relational Frame Theory, with David Palmer and Josh Pritchard. Shillingsburg, et al. (2016). A Preliminary Procedure for Teaching Children with Autism to Mand for Social Information. Frampton and Linehan (2024). The effects of a training package to teach note taking on the formation of equivalence classes. Sponsor shoutouts! Office Puzzle: A thriving ABA practice depends on systems that actually support your team, not slow them down. If you've struggled with software that's buggy, hard to navigate, or offers little support when you need it most, you're not alone. That's why so many practices are switching to Office Puzzle. Go to officepuzzle.com/bop to learn more! Frontera. Consider taking a demo of Frontera's Assessment Builder and see how the ethical application of AI technologies can help you serve clients and save you time! Your first assessment report is free. And if you use code BOP25 you'll get an additional five assessments for just $100. So head to fronterahealth.com to check it out! MindBodyBehavior's Certified Health Coach Program. If you're a BCBA looking to use your ABA skills to help people live healthier lifestyles, learn how to do it the right way, with expert instruction, mentoring, and guidance from Sarah Burby. Better still, podcast listeners can save $$$ by using the code BOP10 at check out. Click here to learn more! The 2026 Stone Soup Conference! This is one of the best values in the online conference space. I'm actually going to be one of the speakers at this year's event, along with a great cast of other characters you're probably familiar with. Save on your registration by using promo code PODCAST26! The 2026 Verbal Behavior Conference! Taking place March 26–27, 2026, in Austin, Texas, or livestream and on-demand on BehaviorLive. Presenters will include Drs. Mark Sundberg, Patrick McGreevy, Caio Miguel, Alice Shillingsburg, Sarah Frampton, Andresa De Souza, and Danielle LaFrance will share how Skinner's analysis of verbal behavior can guide the assessment and treatment of generative learning challenges in children with autism and other developmental disabilities. And don't miss the special pre-conference workshop on Wednesday, March 25.

practice talking about trends

practice talking about trends

learn to talk about trends

learn to talk about trends

learn to talk about trends